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Purpose and Background:  
The aim of this paper is to investigate the causal effect of the timing of Kasai procedure, a 
surgical intervention, on Biliary Atresia (BA) patient outcomes using quasi-experimental 
techniques developed in economics and education. BA is a rare pediatric disease and is the 
most common cause of liver disease-related death in children. The causes of BA are not 
well established and are probably multifactorial. The Kasai procedure is usually 
performed at the early stage of disease, within the first few months of a patient’s life. 
Although performance of the Kasai procedure before 60 days of age suggests improved 
prognosis, no available research to date has investigated the causal effect of the timing of 
the Kasai procedure on patient outcomes.  
Methods: 
This study uses data drawn from the Japan Biliary Atresia Registry. The dataset 
contains a total of 2743 patients; 1743 girls, and 1000 boys registered since 1989 to 2012. 
Subjects were eligible for study inclusion provided that they were born between 1989 and 
 
 
2012 and underwent the Kasai procedure. In addition, eligible subjects had to have had an 
observable primary predictor variable and outcome. The primary predictor variable was the 
age at Kasai procedure and the outcome was 1-year native liver survival without jaundice. 
Other variables included in the analyses were sociodemographics (i.e. gender, birth order, 
birth weight, gestational age, parental age), clinical characteristics (i.e. types of obstruction, 
associated anomalies, type of choleretic agents), and hospital characteristics defined as 
hospital caseload. Bivariate analysis, multivariate logit/probit regressions, stratified 
multivariate logit regression, hospital fixed effects, and instrumental variable (IV) 
approaches were conducted.  
Findings:  
The IV approach was used to examine whether the timing of the Kasai procedure 
was endogenous in the model. Although using the length of stay at the last hospital prior to 
Kasai procedure as a proxy for accessibility to the nearest high-level hospital had its 
strengths as the instrument as confirmed by the first-stage diagnostics, the Wu-Hausman 
test indicated that the estimates of the model with and without IV were consistent.  
 The results from the multivariate covariate-adjusted logit regression suggested that 
for patients with obstruction types I and I with cyst, the timing of Kasai procedure was not 
associated with 1-year native liver survival.  
 
 
However, in patients with type III obstruction (the majority of BA patients [86%]), 
when comparing to the timing of Kasai procedure at 61 to 75 days, the timing of Kasai 
procedure at less than 30 days was suggestively associated with the primary outcome of 
1-year native liver survival without jaundice (log-odds ratio: 0.43 [t=1.79]). This was 1.5 
times as likely to achieve 1-year native liver survival without jaundice while holding other 
variables constant. The timing of Kasai procedure after 76 days had a statistically negative 
association (log-odds ratio: -0.36 [p<0.05]) with the outcome. Moreover, the Kasai 
procedure at 106 to 121 days of age decreased the log odds of 1-year native liver survival 
without jaundice by 0.83, which equated to an increase in likelihood of achieving the primary 
outcome of 0.43 times. The Kasai procedure after 121 days of age also decreased the log 
odds of the outcome by 1.17 that was 0.3 times as likely to achieve 1-year native liver 
survival without jaundice. These differences are quite significant; therefore, the effort to 
increase the patients who could have the Kasai procedure at less than 30 days and to 
prevent the Kasai procedure after 76 days should be made to improve 1-year native liver 
survival without jaundice for the type III patients.  
As previously suggested, cholangitis and the use of corticosteroid have a negative 
association with the outcome after adjusting for covariates. Ursodeoxycholic acid indicates a 
positive association with the outcome, as does the hospital caseload, even when both are 
 
 
adjusted for covariates. 
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This study aims to investigate the causal effect of the timing of a surgical 
intervention, the Kasai procedure, on Biliary Atresia (BA) patient outcomes by applying the 
methods employed in economics and education. A randomized experiment provides the 
most persuasive strategy for answering causal questions regarding the impact of specific 
interventions. However, designing a randomized control trial (RCT) is not always the best 
approach for answering a causal question in the fields such as economics, education, and 
medicine because of factors such as cost or ethical constraints. Instead of performing a 
RCT, observational studies offer an alternative source for developing scientific evidence 
regarding the effectiveness of different treatments; however, a major challenge for 
observational studies is to overcome bias due to unobserved confounding.  
In the face of limited economic resources, prudent allocation and prioritization of 
spending are vital. In fact, the idea of prioritized spending is universal across fields. 
Decisions for resource allocation should to be based, preferably, on scientific evidence of 
relative effectiveness. To evaluate the effectiveness of any given intervention is to estimate 
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the causal effect of one treatment compared to another. However, scientific evidence on 
treatment effectiveness for rare diseases is particularly lacking, and therefore continued 
research is typically needed.  
Development of statistical methods to estimate the effectiveness of Educational 
programs has provided us with a better understanding of important patterns within available 
data, and the ability to test specific hypotheses in economics and education. This 
progression in the development of analytical methodologies has contributed to a major 
evolution in educational research in the U.S. (Murnane and Willett, 2011).  
As much of the research conducted economics and education is based on 
real-world observational data, it is important to effectively address the issue of confounding. 
In fact, the impact of confounders on the estimation of a causal treatment effect can be 
mitigated by methods developed and used in economics and education. Researchers in 
economics of education often try to learn from experiments that occur naturally in order to 
overcome the intrinsic limitations of the observational data. Lessons learned in their 
experiences and methodologies developed during the course of their research could be 
applicable to any other fields where financial and ethical constraints may limit the application 
of RCTs. In this dissertation, I am applying statistical models that are often used in the fields 
of economics and education, but I am applying them in a healthcare research setting. 
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BA is a rare pediatric diseases and is the most common cause of liver 
disease-related death in children (Hartley, Davenport and Kelly, 2009). The causes of BA 
are not well established and are likely multifactorial (Danks et al., 1977; Dillon et al., 1994; 
Hartley, Davenport and Kelly, 2009). The Kasai procedure is a corrective surgery done 
at the early stage of disease, within the first few months of onset/diagnosis. Patient’s 
age at Kasai procedure is one of the main prognostic factors in infants with BA (Chardot et 
al., 2013). Although a performance of the Kasai procedure before 60 days of age is 
associated with improved prognosis, to date, there are no studies in the available 
literature exploring the causal effect of early Kasai procedure on patient outcomes.  
The general overview of BA and the timing of the Kasai procedure and patient 
outcomes will be discussed in more detail in Chapter 2. In the following subsection, I will 
explain the background of this study followed by the crucial period of child development, the 
research question of the study, and the overview of the organization of the study.  
 
1.2. Background  
1.2.1. Rare Disease and Chronic Health Condition in Children  
There is no single definition widely accepted and internationally used for rare 
diseases. Some definitions rely on the number of people living with a disease while other 
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definitions include other factors, such as the existence of adequate treatments or the 
severity of the disease. In the United States, the Rare Diseases Act of 2002 defines rare 
disease strictly according to prevalence. Rare disease is defined as "any disease or 
condition that affects less than 200,000 people in the United States," or about 1 in 1,500 
people. The definition of rare disease includes reference to treatment availability, a lack of 
resources, and severity of the disease. While the term orphan disease is used as a 
synonym for rare disease, the difference is that the term orphan drug is a legal definition in 
the U.S. and EU, and is often used in the context of the orphan drug movement which 
began in the U.S. This movement spawned the U.S. Orphan Drug Act, which is legislation 
designed to facilitate the development and commercialization of drugs to treat rare 
diseases. 
A rare disease is defined by the European Union as one that affects less than 5 in 
10,000 of the general population and there are between 6,000 and 8,000 known rare 
diseases which affect 6 % to 8 % of the population in the course of their lives in the EU 
(EURORDIS, 2005). The EURORDIS, a non-governmental patient-driven alliance of patient 
organizations representing 692 rare disease patient organizations in 63 countries, also 
reports that 1 in 17 people will be affected by a rare disease at some point in their lives. 
What this suggests is that collectively rare diseases are not rare. While individually these 
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conditions are uncommon, as a whole group they are a significant cause of chronic illness in 
both children and adults.  
Moreover, 10-20 million children and adolescents in the U.S. have some form of 
chronic health condition (Pediatrics, 2014). The American Academy of Pediatrics defines 
“chronic” as a duration that lasts from three months to a lifetime. Based on these numbers, 
about 15 to 27% of all children in the U.S. live with a chronic condition1. Living with a chronic 
health condition may disrupt a child’s normal activities, and requires numerous 
hospitalizations and/ or home health care and extensive medical care. 80% of rare diseases 
have identified genetic origins involving one or several genes or chromosomal abnormalities, 
and are present in between 3% and 4% of births. Other rare diseases are caused by 
infections (bacterial or viral), or allergies, or are due to degenerative, proliferative or 
teratogenic (chemicals, radiation, etc). Some rare diseases are also caused by a 
combination of genetic and environmental factors. However, for most rare diseases the 
etiological mechanisms are unknown (EURORDIS, 2005). The EURORDIS also suggests 
that despite this great diversity, rare diseases have some common characteristics, which 
are as follows:  
² Rare diseases are severe to very severe, chronic, often degenerative and 
life-threatening; 




² The onset of the disease occurs in childhood for 50% of rare diseases; 
² The quality of life of rare diseases patients is often compromised by the lack or loss of 
autonomy; 
² Rare diseases are highly painful in terms of the psychosocial burdens: the suffering of 
rare disease patients and their families are debilitated by psychological despair, the 
lack of therapeutic hope, and the absence of practical support for everyday living; 
² Incurable diseases, mostly lack effective treatment. In some cases, symptoms could be 
treated to improve quality of life and life expectancy; 
² Rare diseases are very difficult to manage: families encounter enormous difficulties in 
finding adequate treatment. 
As mentioned, while individually these entities are uncommon, as a whole group 
they are an important cause of chronic illness in both children and adults and the as 
suggested, 1 in 17 people will be affected by a rare disease at some point in their lives 
(EURORDIS, 2005). The complexity and unknown mechanism of each rare disease, using 
an aggregate measure to cover the full range of patients with that disease, is very 
challenging. At the same time, if successful, it can contribute to tailor-made policies based 
on the scientific research to ease the difficulties faced by the patients. In general, people 
with a rare disease have not been registered in identified databases, and many rare 
diseases were summed up as “other disorders” as a consequence. By fully utilizing the 
Japanese Biliary Atresia Registry including 2743 subjects, this study suggests the 
advantage and possibility of generating scientific evidence for the disease with very low 
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incidence in the population. 
 
1.3. Research Question  
 In this dissertation, I aim to answer the following research question:  
Does the timing of the Kasai procedure relative to onset of BA have a causal impact on 
patient outcomes?  
With regard to this research question, my concern is that there might be an 
endogeneity problem, since I cannot fully account for all confounders. For example, in the 
case of BA studies, the timing of Kasai procedure and outcomes are closely related to 
unobserved progression and the severity of disease. A detailed discussion of the 
endogeneity problem will be presented in Chapter 3.  
The strength of this study is that by using the largest available population-based 
dataset, it allows to control for many confounders that could not be accounted for in prior 
studies. In this study, the primary predictor variable was the age at which a patient had the 
Kasai procedure, and the outcome was 1-year survival of native liver without jaundice. Other 
variables included socio-demographics (e.g. gender, birth order, birth weight, gestational 
age, parental age), clinical characteristics (e.g. type of obstruction, associated anomalies, 
and type of choleretic agents), and hospital characteristics (e.g. hospital caseload).  
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Yet, even after controlling for these variables, there may still encounter 
endogeneity bias requiring to consider using alternative statistical methods to correct for the 
unmeasured confounding.  
 
1.4. Overview of the organization of the study 
This study is organized and presented in six chapters. The introductory chapter 
explains the background and broader context of the study, the research question, and an 
overview of its contents and organization. Following to the introductory chapter, the second 
chapter reviews the existing literature, and is divided into two main sections. The first 
section will focus on previous clinical studies of BA and provides an overview of the disease 
followed by more specific topics including the impact of Kasai procedure timing on patient 
outcomes, as well as the types of statistical approaches used in previous analyses. The 
second section will focus on the methodological approach used in the analysis. In particular, 
I reviewed existing literature that employs quasi-experimental techniques in economics and 
education. The potential methodological approaches that were commonly used in the fields 
of economics and education but that could be utilized in this study are discussed and 
summarized in Chapter 2 as well. In chapter 3, I will discuss the foundation of causal 
inference and potential threats to causal inference, especially in observational studies. In 
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addition, I will outline and explore five approaches to mitigate such bias, including 
multivariate logit regression, difference-in-difference (DiD), propensity score matching 
(PSM), fixed effects (FE), and instrumental variable (IV). In chapter 4, I will describe the data 
and sample selection. Additionally, I will discuss the estimation strategy and focus on the 
feasibility of conducting the five approaches suggested in Chapter 3. Chapter 5 will cover 
the results of the bivariate analysis, multivariate logit/ probit regressions, hospital FE, and IV 
analysis, and will provide discussions of our empirical analyses. The last chapter covers the 







The review of existing literature will be broken up into two main parts. The first part 
will focus on previous clinical studies on BA. Specifically this subsection will provide an 
overview of the disease as well as exploring literature followed by the effect of the timing of 
Kasai procedure on patient outcomes, the statistical approaches used in the previous BA 
analyses, and the implementation of stool color card screening.  
The second part will present key methodological approaches developed and used 
in economics and education, focusing on studies that employ quasi-experimental 
techniques in these fields. Since the goal of this study is to examine a casual effect of the 
timing of Kasai procedure on patient outcomes using observational data, it is important to 
consider the application of advanced methodologies developed in economics and education 
for the analysis of BA. The strength of using quasi-experimental methods is that it allows for 
the estimation of a causal effect of a treatment variable when an experimental design is not 
feasible. The potential methodological approaches that are commonly used in the fields of 
economics and education, but that could be utilized in this study will be discussed and 
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summarized in the conclusion of this chapter.     
 
2.2. Overview of Biliary Atresia 
In this subsection, I will review the overview of BA, which covers pathogenesis, 
epidemiology, symptom, diagnosis, types of obstruction, the Kasai procedure, postoperative 
management, liver transplantation, and prognosis of BA.  
 The causes of BA are not well understood and are probably multifactorial. Genetic 
factors may play a role in some cases, but infectious, toxic, or immunologic mechanisms are 
likely involved (Danks et al. 1977; Hartley, Davenport et al., 2009; Tracy et al., 1994).  
Although the overall incidence is low (about one in 10,000 to 20,000 live births), 
there are variations within specific regions (Matsui et al., 1994; Danks et al., 1977; McKierna 
et al., 2000). The worldwide incidence rates of BA are presented in Figure 1.  
 Seasonal and geographic variations shown in Figure 1 have been suggested, but 
not confirmed, to influence outcomes (Yoon et al., 1997; Chardot et al., 2013; Wada et al., 
2007). In terms of socio-economic status of patient, one US study showed that black 
mothers were 2.5 times more likely to give birth to an affected child than were white mothers. 
No association was identified between the disorder and smoking, maternal age, education, 
alcohol use, folic acid intake, gravidity, parity, parental income, infant sex, preterm birth, 
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infant birth weight, or plurality (The et al., 2007); however, the results of this study were 
compromised by the small number of cases (n=62). 
Most infants with BA are born at full term, have a normal birth weight, and initially 
thrive similar to healthy infants. The first sign of BA is jaundice; the onset of which may occur 
any time from birth up to eight weeks of age. If this sign goes unrecognized, it may lead to 
liver failure and eventually death in the first few years of life. BA may occur in isolation (70 
percent), in association with lateralization anomalies such as situs inversus or asplenia2 (10 
to 15 percent), or with other congenital malformations (10 to 15 percent). Those with 
lateralization anomalies have a somewhat worse prognosis than those without anomalies 
(Shneider et al., 2006; Davenport, 2006; Schwarz et al., 2013).   
The diagnosis of BA is made with a series of imaging and laboratory tests, together 
with a liver biopsy to exclude other causes of cholestasis; however, a definitive diagnosis of 
BA is only made after a cholangiogram is performed, which is usually done intraoperatively. 
If the diagnosis of BA is confirmed, a Kasai procedure is performed. Infants should be 
evaluated as rapidly as possible because the success of the surgical intervention diminishes 
progressively with increasing age at surgery (Chardot et al., 1999; Chardot et al., 2013; 
Serinet et al., 2009; Lien et al., 2011).   
                                                   
2 See the classification of each category Table 1.  
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The anatomic pattern of BA is also identified at time of the Kasai procedure. In 
Japan, the anatomic pattern is divided into the four categories shown in Figure 2. The study 
done by Superina et al (2011) was to evaluate the impact of types of anatomic pattern and 
specific clinical factors on achieving successful surgical drainage, as defined by achieving a 
total bilirubin less than 2.0 mg/dL anytime within the first 3 months following surgery using 
logistic regression. They also examined the risk factors associated with transplant-free 
survival over the follow-up period using Cox models. Type II or III (atresia at the porta 
hepatis) was associated with a lower probability of achieving successful drainage compared 
to Type I (atresia of the common bile duct, or so called correctable atresia), although this 
difference did not achieve statistical significance (OR 0.29, p=0.086). In their study, Type I 
with cyst was not classified separately, and was instead included in Type I. In contrast to the 
weaker association of anatomical features with bile drainage, types of obstruction were 
associated with survival. Specifically, Type II or III (atresia at the porta hepatis) was 
associated with a greater risk of transplant or death compared to Ohi Type I (HR 2.03, 
p=0.030).  
The Kasai procedure is a corrective surgery3 done at the early stage of BA, 
usually within the first few months of life. During this surgery, the surgeon removes any 
                                                   
3 See Figure 3 
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problem bile ducts outside the liver. The small intestine is then attached to the liver, 
providing a pathway that can allow bile to drain from the liver. The Kasai procedure is not a 
cure for BA, and it is not effective if the bile ducts inside the liver are damaged or missing. 
However, in many cases, the procedure can improve liver function in patients with BA for 
many years post intervention. In Western countries, short-term clearance of jaundice, 
which is considered as a prognostic factor for long-term outcomes, was 
reported in 50–60% of cases (Davenport et al. 2011), 30–40% of the  patients can 
reach 10 years with their native liver (Stringer 2008). It is recommended that all infants 
with BA undergo a Kasai procedure4. Age at Kasai procedure is a main prognostic factor in 
infants with BA (Lien et al., 2011; Chardot et al., 1999; Chardot et al., 2013). Although a 
Kasai procedure before 60 days of age is associated with improved prognosis, no literature 
has focused on a causal effect of early Kasai procedure on patient outcomes. More detail 
review of the effect of the timing of Kasai procedure will be discussed in the next 
subsection.   
Postoperative management following a Kasai procedure consists of interventions 
such as the use of choleretics and possible use of anti-inflammatory medications, nutritional 
rehabilitation, fat-soluble vitamin supplementation, prevention of cholangitis and 
                                                   
4 It is recommended as Grade 1B on UpToDate which is an evidence-based, physician-authored clinical decision 
support resource which clinicians trust to make the right point-of-care decisions.. A Grade 1B recommendation is a 
strong recommendation, and applies to most patients. Clinicians should follow a strong recommendation unless a 
clear and compelling rationale for an alternative approach is present. 
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management of portal hypertension. The use of choleretics5 such as ursodeoxycholic acid 
is standard practice in BA. Observational studies suggested a number of possible benefits 
of treatment with ursodeoxycholic acid, ranging from enhanced weight gain to reduced 
episodes of cholangitis and improved bile flow, but definitive evidence from randomized 
trials is lacking (Meyers et al., 2003).  
Clinical evidence does not support routine use of steroids6 (corticosteroids) in the 
treatment of BA. This was shown in a randomized placebo-controlled trial of 
steroid treatment in 140 infants with BA (Bezerra et al., 2014). Steroid therapy was given for 
13 weeks and outcomes were measured at 6 and 24 months post Kasai procedure. No 
statistically significant benefit in bile drainage at six months post operation was observed in 
the infants treated with steroids as compared with the placebo group. In addition, no 
statistically significant improvement in survival with native liver at two years of age was 
observed in the treatment group. Moreover, the infants treated with steroids had significantly 
earlier onset of serious adverse events as compared with those given placebo.   
Cholangitis is a common complication in patients with BA who have undergone the 
Kasai procedure. The incidence of cholangitis in these patients is between 40 and 90 
                                                   
5 See Table 1 for the descriptions of types of choleretics 
6 See Table 1 for the description of steroid 
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percent, with the majority of patients experiencing at least one episode prior to two years of 
age (Luo and Zheng, 2008; Oh et al., 1995).  
Even in the current development of the liver transplantation technique and 
post-operation management, at least 60 to 80 percent of patients with BA will eventually 
require a liver transplant. Liver transplantation is indicated for portal hypertension 
complications (recurrent variceal bleeding or intractable ascites), growth failure, and 
progressive liver dysfunction (Davenport, 2006; Nio et al., 2010; de Vries et al., 2011). 
 Although long-term prognosis for BA patients is variable, the complementary and 
sequential approach of the Kasai procedure and liver transplantation affords long-term 
survival with upwards of 90 percent of BA patients surviving into adulthood (Barbara E. et al, 
2008; Chardot et al., 2013).  
Although performance of the Kasai procedure clearly improves overall survival, the 
long-term prognosis is difficult to predict. The three important prognostic factors for surgical 
outcome are the types of obstruction of BA, younger age at the Kasai procedure and the 
expertise of the surgeon and care center at which the Kasai procedure is performed 
(Chardot et al., 1999; Chardot et al., 2013). Children born without atresia, categorized as 
type I obstruction, have the lowest risk of death or transplantation by two years of age (Nio 
et al., 2006; Superina et al., 2011).  
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Clinical outcomes after many complicated surgical procedures vary widely across 
hospitals and surgeons, and in a real-world setting, it is difficult to measure the respective 
skill-level of surgeons. Previous studies suggest that surgical success is dependent on the 
expertise of the center and surgeon (Chardot et al. 2013; Davenport et al. 2004; Nio et al. 
2003). It appears that a center that performs at least five Kasai procedures per year has a 
better success rate, as measured by 5- or 10-year long-term survival with native liver 
(Chardot et al. 2013; Davenport et al. 2004; Nio et al. 2003). In my hypothesis, a surgeon’s 
proficiency increases with experience as a result of their individually accumulated caseload. 
However, the hospital caseload would not necessarily account for each surgeon’s 
experience and skills, but rather the characteristics of the hospital. Empirical data are 
lacking on the relationships between technical skill and postoperative outcomes. 
 
2.2.1. Timing of Kasai Procedure on Patients’ Outcomes 
 The early diagnosis and the timing of Kasai procedure could have different yet 
significant short to long-term implications. The definitive diagnosis of BA is made 
intraoperatively. This means that if the diagnosis of BA is confirmed, the Kasai procedure is 
performed. Although the Kasai procedure before 60 days of age suggests improved 
prognosis, this widely accepted perspective is based on an observed association, not a 
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causal relationship.  
 The basis for testing the relationship between the timing of a Kasai procedure and 
patient outcomes is that a relatively small shift in the timing of the  procedure (e.g. a few 
weeks to a month) would eventually have a relatively large effect on patient outcomes such 
as a clearance of jaundice and native liver survival. If no clearance of jaundice is achieved 
through the Kasai procedure or when complications of biliary cirrhosis appear later on, liver 
transplantation is eventually needed.  The later in life the transplantation is performed, the 
lower the associated morbidity and mortality rates. 
 The study performed by Lien et al. (2011) showed that the introduction of a 
nationwide stool color card was associated with a decrease in the median time to diagnosis 
from 47 to 43 days and an increase in the percentage of patients receiving their Kasai 
procedure within 60 days (from 60% before the program to 74% after implementation). This 
small change in time to the Kasai procedure was associated with an increase in 5-year, 
jaundice-free survival with native liver from 27% to 64%, and in overall survival from 56% to 
89%. (Lien et al. (2011) 
The severity of the liver damage at the time of Kasai procedure may be affected by 
many factors, both known and unknown, which could eventually affect the outcome. It may 
be that age is only a gross reflection of the cumulative damage to the liver thought the onset 
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of the disease, which for some patients may begin at the prenatal stage of development. 
Apart from age, other factors may also alter the tempo of progression to cirrhosis and 
irreversible damage. Previous studies have suggested that the age at surgery may not be 
independent of other variables such as inflammation, fibrosis, size of ductules in the excised 
specimen, hepatic stellate cell activation, poor nutritional status, and BA phenotype. 
The systematic review by Jimenez-Rivera et al. (2013) investigated the 
population-based literature to assess international variation of BA incidence and outcomes 
and newborn screening. In particular, their focus was on the relationship between the timing 
of the Kasai procedure and patient outcomes, centralization of surgical Kasai procedure7 
and implementation of screening for BA as a national health system.  
Their inclusion criteria for the review were that studies should be population-based 
and also include outcomes of interest, including overall survival, survival with native liver, 
and the timing of Kasai procedure. A total of 3,128 reports were identified through searches; 
2,081 were retained for screening after excluding duplicate records. Of these, 149 articles 
were reviewed in full and 36 articles qualified for inclusion. An additional 4 studies were 
identified for inclusion from the reference lists of review articles and recent pertinent 
publications search, and therefore a total of 40 articles were included in the review.   
                                                   
7 A center that performs at least five Kasai procedures per year has a better success rate, as measured by 5- or 
10-year long-term survival with the native liver has been suggested (Chardot et al. 2013; Davenport et al. 2004; Nio 
et al. 2003). 
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According to the results of the review, there were 14 studies that analyzed the 
relationship between the timing of Kasai procedure and patient outcomes. The conclusions 
presented and a summary of the findings in table 2. All studies except for one (De Vries et 
al., 2012) demonstrated improved survival of native liver when surgery was performed at an 
earlier age.  
Tiao et al. (Tiao et al., 2008) studied 327 BA patients born between January 1996 
and December 2003 in Taiwan. Kaplan–Meier curves were used to assess patient survival 
while a log–rank test provided statistical comparisons between those who underwent a 
Kasai procedure before 60 days old and those who went at least 60 days. Furthermore, 
patient survival with native liver was analyzed using time from birth until either death or liver 
transplantation. An analysis of overall survival used time from birth to death. The 5-year 
survival rate with native liver was higher in those who underwent Kasai procedure before 
60 days of age than those underwent the procedure after that time point 
(53.7% vs 36.7%, p = 0.017). However, the 5-year overall survival rate was not different 
between those who underwent a Kasai procedure before 60 days age and those who had 
the procedure on or after 60 days (69.5% vs. 63.6%, p = 0.572). This study also found that 
the 5-year overall survival rate during 1999–2003 was higher than that during 1996–1998 
(74.8% vs 61.1%, p = 0.014). Though their results were based on two group comparisons, 
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there was a statistically significant difference between early and late Kasai procedures, with 
those having an early Kasai procedure demonstrating a higher 5-year survival rate with 
native liver. 
A study by Lien et al. included 191 patients treated between 1990-2005 (Lien et al., 
2011). BA patients were divided into three cohorts; those in cohort A were born before a 
stool card screening program8 (1990-2000); those in cohort B were screened by the stool 
card regional screening program (2002-2003); and those in cohort C were screened by the 
stool card universal screening program (2004- 2005). The relative odds ratios were 
computed using logit regression. The Kaplan-Meier method and a log-rank test were also 
used to assess factors affecting survival.  
The timing of the Kasai procedure at less than 60 days was 49.4% and 65.7% in 
cohorts A and B+C, respectively (p= 0.02). The jaundice-free (total serum bilirubin <2.0 
mg/dL) rate 3 months after surgery was 34.8% and 60.8% in cohorts A and B+C, 
respectively (p<0.001). The 3-year jaundice-free survival rate with native liver was 31.5% in 
cohort A and 56.9% in cohort B+C (p < 0.001), whereas the 3-year overall survival rates 
were 64.0% and 89.2%, respectively (p<0.001). The 5-year jaundice-free survival rate with 
native liver was 27.3% in cohort A and 64.3% in cohort B (p < 0.001), and the 5-year overall 
                                                   
8 The detail of stool color card will be discussed in the next subsection.  
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survival rates were 55.7% and 89.3%, respectively (p < 0.001). In their study, jaundice-free 
survival with native liver was considered as the quality outcome. Cohort B+C had higher 
rates of 3- and 5-year jaundice-free survival with native liver than cohort A (OR 2.87, p 
= 0.001, and OR 4.80, p = 0.001, respectively).  
Patients who received a Kasai procedure before 60 days of age had better 3- and 
5-year jaundice-free survival with native liver than patients who received an operation after 
60 days of age (OR 3.25, p < 0.001 and OR 2.63, p = 0.02, respectively). Quality outcome 
was defined as jaundice-free survival with native liver. All survival time was calculated after 
the date of the Kasai procedure. In their logistic regression analysis given in Table 3, the 
age at Kasai procedure was statistically significant (OR 3.25, p < 0.05 for <60 days) while 
controlling for stool color card program which was also statistically significant (OR 2.87, p < 
0.001), prophylactic antibiotics which was statistically significant as well (OR 3.03, p < 0.01), 
and sex of child which was not statistically significant (OR 1.25, p =0.58 for male).  
This analysis is more reliable than others in terms of controlling for the possible 
confounding; however, they only account for the use of stool color card, gender, and use of 
prophylactic antibiotics. There could be other unobserved characteristics that might affect 
both the timing of the Kasai procedure and outcomes but not in the model. Moreover, the 
use of prophylactic antibiotics might be affected by selection bias, in which medical doctors 
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might have prescribed prophylactic antibiotics for patients whose background characteristics 
were different from those who were not prescribed e.g. worse or better condition.  
 The main purpose of the study done by Hsiao et al. (2008) was the same as Lien et 
al. (2011), focusing on the evaluation of a color card screening process. The study included 
74 neonates born between January 2004 and December 2005 in Taiwan who were divided 
into 2 groups according to region of birth. The chi-square test and Fisher's exact test for 
categorical variables and the Student t test for continuous variables were used. BA infants 
who received an early Kasai procedure (prior to 60 days old) had a higher jaundice-free rate 
(72% versus 33.3%, p = 0.002) than those operated on after 60 days. However, these 
results should be interpreted with caution as the analysis did not account for any potential 
confounding.  
A study in Canada was conducted that included 349 patients who were born and 
diagnosed with BA from 1985 to 2002 (Shneider et al., 2006). In order to control for 
time-variant factors, they analyzed them by dividing subjects into two groups: the first era, 
January 1, 1985 to December 31, 1995; and the second era, January 1, 1996 to December 
31, 2002. Kaplan-Meier survival analysis was done with overall patient survival, defined as 
the period starting at birth and ending at death or last follow-up; liver transplantation survival 
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beginning at transplantation and ending at death or last follow-up; and native liver survival 
starting at birth and ending at death, transplantation, or last follow-up.  
Univariate analysis was done using rank-sum and log-rank tests. The median 
patient age at the time of the initial referral to a tertiary care pediatric hospital center was 55 
days (ranged 1 to 191 days). Four year survival rates with native liver were assessed by 
Kaplan-Meier survival curves for patients undergoing a Kasai procedure at age ≤30, 31 to 
90, and >90 days showed that 49%, 36%, and 23% (p < .0001), respectively. This difference 
continued through 10 years. A total of 40% (6 out of 15) in the first era and 72% (13 out 
of18) in the second era (p-value was not reported) were referred at age >90 days. The 2- 
and 4-year post-Kasai procedure native liver survival rates were 47% and 35% for the first 
era and 46% and 39% for the second era (p-value was not reported).  
This analysis suggested that there was a statistically significant lower probability of 
survival with a native liver at 4 years post operation compared to Kasai procedures done at 
age ≤30, 31 to 90, and >90 days. However a post hoc test to determine factors leading to 
the differences were not performed. They did not observe a significant era effect on the 
post-Kasai operation native liver survival rates although they did not control any other 
possible confounders. They did not observe a significant era effect on the post-Kasai 
operation native liver survival rates, yet it seemed to have the late referral problem which 
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contributes to diminish post-Kasai operation native liver survival rate.  
 A study in Brazil (Carvalho et al., 2010)9 included 513 patients born and diagnosed 
as BA from 1982-2008 in six Brazilian medical centers. 76.4% of total patients underwent 
Kasai procedure of the mean age of 82.6 days (±32.8 SD). The 4-year post-Kasai procedure 
survival with native liver was 36.8%, inversely correlated with age at Kasai procedure (54, 
33.3, 26.6% for ≤ 60, 61-90, > 90 days, respectively). The statistical test and significance 
were not reported.  
 A study in Switzerland (Wildhaber et al., 2008) included 48 patients with BA born in 
between January 1994 and December 2004. Survival rates were calculated with the 
Kaplan-Meier method, and prognostic factors were evaluated with the log-rank test. 
Forty-three children out of 48 underwent Kasai procedure. Median age at Kasai operation 
was 68 days (range, 30 – 126). The 4-year survival with native liver after Kasai operation 
was 37.4%. However, 4 -year survival with native liver was 75% in patients who underwent 
Kasai procedure before 46 days, 33% in patients operated on between 46 and 75 days, and 
11% in patients operated on after 75 days (p = 0.02). The authors observed that survival 
with native liver after Kasai procedure was linked to the clearance of jaundice 
post-procedure. The study also found that 2- and 5-year survival with native liver was 
                                                   
9 Only the abstract was available in English.  
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92.3%±7.4% and 83.9%±10.4% in patients with successful Kasai 10operation, 60%±21.9% 
and 60%±21.9% in patients with intermediate results following Kasai procedure, and 
4.8%±4.6% and 0% in patients with failed Kasai procedure (p < 0.01). It should be noted that 
the study used a relatively small sample size..  
 A study in France (Chardot et al., 1999) included all patients with BA born in the 
years 1986 to 1996. The study included 472 patients. 5- and 10-year actuarial survivals with 
native liver rates were 32% and 27%, respectively. In the univariate analysis, better rates of 
survival with native liver are associated with the performance of Kasai procedure, and the 
age at Kasai procedure (performed prior to 45 days of age). (41% 31% for 5 year by less 
than 45 days and over 45 day, 41% 26% in 10 years respectively).  
 In their multivariate analysis to investigate the predictors survival with native liver, 
overall survival, and survival with liver transplantation, Chardot et al. controlled for the 
anatomical pattern of BA, the associated anomalies, and the center with large experience in 
the management of BA patients. The study results are shown in Table 4. The relative risk of 
survival with native liver for the patients with Kasai procedure after 45 days of age when 
compared to less than 45 days was 1.4 (CI:1.03-1.9, p<0.01). The results also suggest that 
patients with type III anatomic pattern have a higher risk of not achieving survival of native 
                                                   




liver (RR 4.1, CI 2.1-8.0, p<0.01), as do patients with associated anomalies  (RR 1.7, CI 
1.1.-2.5, p<0.05). Also, patients treated at a hospital with less than five Kasai operations per 
year were indicated to have a higher risk  of failure to achieve native liver survival 
compared to hospitals with more than 20 Kasai operations per year (RR 1.6, CI 1.3-2.1, 
p<0.01).  
 The cut-off timing of Kasai procedure differed from that used in the multivariate 
analysis by Lien et al (2011). Chardot et al. divided the timing of Kasai procedure at the 45 
day instead of the 60 day. As the authors note, the 45 day time point was used since, in their 
univariate analysis, an earlier Kasai procedure was associated with a better prognosis for 
patients who had the procedure prior to 45 days of age (41% 31% for 5 year by less than 45 
days and over 45 day, 41% 26% in 10 years respectively).  
In a 1999 study, Chardot et al. used the same national data source described 
above, but investigated the timing of Kasai procedure by different categorical groups and 
with more subjects (Chardot et al., 1999). The authors classified patients into three groups: 
group 1 (n = 30), no contraindication to the Kasai procedure, but orientation to de novo 
transplantation; group 2 (n = 380), age at Kasai operation <90 days; and group 3 (n = 60), 
age at Kasai procedure >90 days. Survival with native liver, survival after liver 
transplantation, and overall survival were assessed using the Kaplan-Meier method, and 
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were compared using a log-rank test.  
The results of the Chardot et al. (1999) suggested that five-year and10-year 
survival with native liver was 35% and 30% in group 2 and 25% and 22% in group 3 (p = .03). 
Five-year overall survival was 57%, 74%, and 55% in groups 1, 2, and 3, respectively (p 
= .003). Unlike their previous study, the authors did not control for any confounding in this 
study.  
In a 2013 study, Chardot et al. continued their research on the long-term outcomes 
(Chardot et al., 2013). This study explored the same population-based data but over a 
longer period (1986 to 2009), with a sample population of 1107 patients. Patients were 
divided into 3 cohorts according to their years of birth: 1986–1996, 1997–2002, and 2003–
2009. Survival rates were estimated according to the Kaplan-Meier method. Univariate 
analyses were performed using a log-rank test. Multivariate analyses, when appropriate, 
were performed using a Cox regression model (presented in Table 5). Study results showed 
a median age at Kasai operation of 59 days, unchanged over time. Twenty-year survival of 
native liver was 39%, 32%, 28%, and 19% after Kasai operation performed in the first, 
second, third months of life or thereafter, respectively (p= 0.0002).  
While controlling for the types of obstruction and associated anomalies, the relative 
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risk of failure to achieve a survival of native liver increase as the timing of Kasai procedure 
advances, when compared to the group with Kasai procedure after 90 days (RR 0.54 CI 
0.37-0.76 for less than 31 days; RR 0.59 CI 0.45-0.75 for 31-60 days; RR 0.75 CI 0.37-0.79 
for 61-90 days; p<0.01). In accordance with their previous study, the anatomic pattern of 
type III showed a worse prognosis (RR 0.69 CI 0.54-0.87 for Type 3; RR 0.47 CI 0.32-0.71 
for Type 2; RR 0.13 CI 0.04-0.4 for Type 1) which was statistically significant at 0.01%. Also, 
associated anomalies showed the worse prognosis (RR 0.59, CI 0.45-0.78, p<0.01).   
 Unlike their previous study, the authors did not include hospital caseload in their 
multivariate analysis. This reason for this was that by comparing three cohorts according to 
the years of birth, the first cohort showed better results for Kasai procedures performed in 
hospitals with the highest caseloads (20 cases per year); however, the Kasai procedure 
outcome results were not statistically different according to the hospital caseloads in the 2nd 
and 3rd cohorts.  
Another France-based study used the same national data that Chardot et al (2009, 
2013) employed; although, the study included patient data up to 2002 (Serinet et al., 2009). 
A total of 695 out of 743 included subjects underwent a Kasai procedure. The 2-, 5-, 10-, 
and 15-year survival rates with native liver were 57.1%, 37.9%, 32.4%, and 28.5%, 
respectively. Median age at Kasai operation was 60 days and was stable over the study 
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period. Whatever the follow-up (2, 5, 10,or 15 years), survival rates with native liver 
decreased when age at surgery increased (<30, 31–45, 46–60, 61–75, and 76–90 days) 
and the difference among those groups was statistically significant (p=0.0001), as shown in 
Figure 4. Kaplan-Meier analysis and the log-rank test were performed. They concluded that 
that the earlier the Kasai procedure, the better its results, especially in the subgroup of 59 
patients operated on within the first month of life. Yet the outcome was worse in 9 of 92 
patients who underwent a Kasai operation in the first month of life, suggesting that early 
diagnosis might have been related to a different pathogenesis of the disease, associated 
with a worse prognosis.  
The findings of this series of French studies described above are informative, 
particularly those that controlled for confounding. In addition, the studies which assessed 
different Kasai procedure timing cut-offs (i.e. those other than the standard 60 days of age) 
provide useful insights into the role of this timing in overall outcomes. Also they investigated 
the different timing of the Kasai procedure rather than looking at the widely accepted 
notation of the Kasai procedure before 60 days of age.  
A study in the Netherlands assessed liver status and health perception among 
Dutch patients who survived 20 years after therapy and investigated whether the rate of 
transplant-free survival increases with time (De Vries et al., 2011; De Vries et al., 2012). The 
31 
  
authors used a Dutch national database for BA which includes 104 patients born between 
1977 and 1988. The study results demonstrated that the 20-year transplant-free survival 
rate increased from 20% (10 of 49) in the 1977 to 1982 cohort to 32% (18 of 55) in the 1983 
to 1988 cohort (p = .03). Survival was significantly lower when patients underwent surgery 
after 75 days when compared with 60 to 75 days (11% ±6% vs 42% ±10%, respectively, p 
= .03), as shown in Figure 5. The authors used the Kaplan-Meier method and log-rank test 
for group comparisons. Unlike the other studies presented above, their findings on survival 
of native liver showed a somewhat mixed result. The 20-year survival rate was not 
significantly associated with the age at surgical correction. Interestingly, the best prognosis 
group had the Kasai procedure at 60 to 75 days followed by 45 to 60 days. Moreover, they 
reported that one fifth of the 20-year transplant free survivors had no signs of cirrhosis.  
 The analysis by Karrer et al. (Karreret al, 1990) used data from a registry including 
904 children with BA drawn from more than 100 institutions. Patients included in the registry 
were born between 1967 and 1989 in the U.S. The 5-year actuarial survival was 62.5% 
(Kasai procedure <30 days), 43.6% (Kasai procedure 31-60 days), 39.5% (Kasai procedure 
61-90 days), 28.6% (Kasai procedure 91-120 days), and 28.8% (Kasai procedure >120 
days; p=0.023) Kaplan-Meier analysis and statistical comparisons using the Cox-Mantel test 
were conducted. Mean age at which the Kasai procedure was typically performed at present 
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has not changed significantly.  
 While previous literature suggested that the timing of the Kasai procedure was 
associated with the patient outcomes, only three studies tried to control for covariates in 
their respective models. The Taiwan-based study (Lien et al., 2011) controlled for gender, 
use of stool color card, and prophylactic antibiotics in their multivariate analysis. the age at 
Kasai procedure before 60 days was statistically significant.  
In Chardot et al (1999)’s multivariate analysis, factors such as the anatomical 
pattern of BA, associated anomalies, and each center’s level of experience with the 
management of BA patients were addressed. The Kasai procedure after 45 days of age as 
compared to less than 45 days increased the relative risk of failing to achieve a native liver 
survival.  
The later study by Chardot et al (2013) also controlled for the types of obstruction 
and associated anomalies, the relative risk of failing to achieve a survival of native liver 
increased with increasingly later timing of the Kasai procedure defined as starting from 30 
days of age added by 15 days.  
In summation, although the association between the timing of Kasai procedure and 
survival of native liver has been suggested in many studies, the causal effect of Kasai 
procedure have not yet fully been investigated. The possible categorization for the timing of 
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Kasai procedure will be less than 30 days and added up by 15 days since the earlier 
intervention seemed to larger impact on the later outcomes in France study with the largest 
sample size in the existing study (Chardot et al 2009, 2013). They found that the earlier the 
Kasai procedure, the better the prognosis. Especially in the subgroup of 59 patients 
operated on in the first month of life, wherein the outcome was better than in the children 
operated on later in their lives.  
 
2.2.2. Implementation of Stool Color Card 
 Since the previous studies present findings suggesting that the earlier age at Kasai 
procedure is associated with an increase in the long-term prognosis of patients, these 
results further support the need for effective BA screening. In fact, effective screening is the 
key to initiating a successful early intervention, since the diagnosis of BA is made with a 
series of exams including imaging, laboratory tests, and liver biopsy to exclude other causes 
of cholestasis, all of which could take a few days to a few weeks to collect and assess. Even 
after the various diagnostic tests, definitive diagnosis of BA can only be made 
intraoperatively.  Once the diagnosis of BA is confirmed, the surgeon performs a Kasai 
procedure. Infants should be screened and evaluated as rapidly as possible because the 
surgical intervention’s success depends on such a short period of time, between few weeks 
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to few months of age. Therefore, in this subsection, I will overview the evolution of the most 
widely used screening tool, the stool color card, and will look at the evaluation of the 
effectiveness of such a screening.  
Japanese Studies 
In Japan, beginning in April of 1987, the question asking “what color is your baby’s 
stool?” with a footnote recommending “jaundice infants with alcholic or white stools need to 
see a pediatrician immediately” was included in a Mother and Child Health Handbook11. To 
assess the impact of this introduction, a study performed by Matsui (Matsui et al., 1995) 
compared the age at time of Kasai procedure in two groups, before-and-after the 
implementation. The first group included 83 patients born from January 1982 to March 1987 
(before introducing the specific question in the Mother and Child Health Handbook) and the 
second group consisted of 93 patients born between May 1989 and April 1991. According to 
their results, the age at Kasai operation did not significantly differ between the two groups 
(the level of significance was not reported).  
Following the report in 1994, Matsui et al. conducted a pilot study for 
mass-screening by using a stool color card including the pictures of normal and pale 
                                                   
11 In Japan, all parents received a Mother and Child Health Handbook from a local municipality when they report 
their pregnancy. The booklet includes forms for prenatal checkups, a birth notification form, and information about 
available prenatal classes. The handbook also works as a “fact-sheet” recorded by as both medical institutions and 
parent. It contains the information on the mother's health, the progress of pregnancy and childbirth conditions, and 




pigmented stools in Tochigi Prefecture in Japan (Matsui et al,, 1995). They distributed the 
color card at maternity hospitals and mothers were asked to compare the stool color of 
infants with the referenced colors printed on the card. Doctors checked for infant’s jaundice 
and the suggested stool color by a mother, and they reported cases needing further 
attention. They screened 17,641 infants from 1994 to 1995 and identified two out of three 
infants with BA during the period. Although this pilot study covered a large number of infants, 
since the incidence rate of BA was quite low, and the number of infants screened was not 
enough to perform any statistical tests. In a subsequent report by Matsui at a National 
Institute of Health workshop in the U.S., he reported that the specificity was 99.9% and the 
sensitivity was 67% (Sokol et al., 2007). According to their analysis, among 147,337 children 
the reported pale stool color at one month identified ten who were affected by BA, but five 
other children for whom there was no claim for pale stool colors were also found to have BA. 
The average days from birth at the Kasai operation was 53 for the screened group and 84 
days in the non-screened group.  
 Muraji (2012) reported that alcholic stool was observed only in 50% of the infants 
before the BA diagnosis based on the Japanese Biliary Atresia Registry data. The author 
analyzed the effect of a color card by comparing patient data before- and 
after-implementation of the color card screening in 1997. The result showed that the median 
36 
  
age at referral increased from 53 days of age in the before-implementation group (n=18) to 
70 days in after-implementation group (n=9) (Muraji, 2012). Two of nine patients were 
detected by color card and four patients presented with the color card at one month 
check-up, two cases were false negatives and the other two were missed. Among the 
remaining three patients, two cystic type patients showed good outcomes, while the other 
did not present the color card at the one month check-up and was detected at 95 days. 
 Muraji (2012) also reported results from an analysis using the Japanese Biliary 
Atresia Registry. Yellow stool was observed in only 55.2% of patients by the parents (1,333 
of 2,417) and only 24% of parents claimed that there was abnormality in stool color in their 
BA infants.  
 Positive results of color card screening had been reported from the pilot study in 
Tochigi in contrast to the report from Ibaraki (Muraji, 2012; Matsui et al., 1996) . There were 
ten regions in Japan which implemented the stool color card screening prior to expanding it 
to a nation-wide screening scheme. However, the official reports on those pilot studies other 
than Tochigi and Ibaraki were not publically accessible. By contacting a respondent at 
regional or district level, I realized that there were great disparities in implementation of 
studies among different regions, which led to mixed results. Some regions offered 
educational lectures to medical staff as well, but some regions did not.  
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Without any scientific investigation on the effect of color card screening, a 
nationwide screening program with the color card has been implemented since April 2012. 
The stool color chart was included in the Mother and Child Health Handbook and asked a 
caregiver to see doctors if stool color of an infant fell into the suggested colors (#1-3 in 
Figure 6). The effect of the nationwide implementation has not been reported yet.  
Taiwan Study 
Prior to Japanese national implementation of the stool color card, Taiwan 
introduced a national stool color card for the early identification of babies with BA in 2004. 
As reported in the previous subsection, Lien et al (2011) employed a logistic regression 
model to estimate the effect of using a stool color card that had been implemented in 
Taiwan. The study compared the outcome of patients before versus after the launch of the 
infant stool color card screening program and concluded that the stool card screening 
program was effective in achieving early diagnosis of BA patients. In the Taiwan-based 
study, the sensitivity was 0.9714 and the specificity was 0.9995.  
However, in their analysis, only gender, prophylactic antibiotics, and age at the 
Kasai procedure were controlled, and as previous literature suggested, other clinical and 
hospital characteristics might have affected the results. In addition to distributing a color 
card, educational lectures were provided to medical staff. Also to enhance better 
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interactions among medical staff and caregivers for screening BA, posters were distributed 
in all hospitals and clinics. Detailed orientations to support the national color card screening 
might have affected the outcome as well.  
Other screening methods for early diagnosis are to measure blood, urine, and stool. 
The early measurement of blood included conjugated bile acids in dried blood spots using 
tandem mass spectrometry, serum conjugated bilirubin after birth, and serum Apo C-II and 
III proteins using surface-enhanced desorption/ionization time-of-flight mass spectrometry 
(SELDI-TOF- MS). The early measurement of urine included measuring urinary sulfated bile 
acid (USBA). The early measurement of stool included measuring fecal conjugated bilirubin 
by near-infrared reflectance spectroscopy. However, none have been put into daily practice 
extensively, due to both cost and technical complexity (Wildhaber, 2012).  
 
2.3. Quasi-experimental Techniques used in Health and Education 
In this subsection, I will review the methodological approaches that were utilized in 
previous studies in the field of economics and education aiming to examine the causal 
relationship between health and education. After the general overview of the statistical 
approach for such causal inference, I will focus particularly on the observational studies 
using a quasi-experimental methods used for examining the relationship between health 
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and education in general, and how researchers have tried to overcome latent endogeneity 
problems.  
 In the field of economics and education, randomized trials are not as common as in 
clinical research; However they are becoming more popular in education (Angrist, 2004). A 
leading randomized study from the field of economics and education is the Tennessee 
STAR experiment designed to estimate the causal effects of smaller classes in primary 
school. Results from the various studies on the Tennessee STAR experiment have shown a 
large effect to smaller classes (Finn and Achilles, 1999; Krueger and Whitmore, 2001). Even 
in the absence of a real experiment, one could try to look for well-controlled covariates 
and/or natural quasi-experiments. The quasi-experimental study of class size by (Angrist 
and Lavy, 1999) illustrates how we can leverage available observational data by designing 
studies that exhibit characteristics of an experimental design. As in Tennessee STAR, in 
accordance to other previous studies, they suggested a strong link between class size and 
achievement12. As used in Angrist and Lavy (1999), the IV approach has been widely used 
in economics and education in their causal estimate. In the following subsection, I will look at 
more detailed methodological approaches taken in selected studies aiming to investigate 
the relationship between health and education.  
                                                   
12 The outcome was the test scores, the explanatory variable was class size, the IV was the indicator for whether 
total enrollment was “just above” a multiple of 40. Their Maimonides’ rules states (roughly) that no class size should 
exceed forty, so that if enrollment (treated as exogenous) is “just below” 40, class sizes will be bigger, whereas if 
enrollment is “just above” 40, class sizes will be smaller. 
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In this subsection, I will examine the evidence from recent non-experimental and 
quasi-experimental studies to look at the effect of health status on education. Endogeneity 
between health and education can arise from unobserved factors that affect both health and 
education. For example, not only do schools and teachers vary in several ways requiring 
great effort to collect all the relevant data on those variables, but also some school and 
teacher characteristics (e.g., teachers’ motivation and principal’s managerial ability) are 
difficult to measure. Also one can have difficulty measuring a child’s innate ability, although 
often IQ is used as a proxy. In addition, parents’ preferences and favoritism are difficult to 
measure. Although, such parental preferences for a child’s health and education are likely to 
be correlated. This leads to another important source of bias called reverse causality.  
 Many researchers use height-for-age as a measure for capturing general health 
status of a child in observational studies (Victora et al., 2008; Jones et al., 2008; Glewwe, 
2005; Glewwe, Jacoby and King, 2001; Glewwe and Kremer, 2006; Alderman, Hoddinott 
and Kinsey, 2006). The indicators of “healthiness” used in observational studies tend to be 
less disease-specific, instead focusing on how to capture a broad picture of a child’s health.  
Not all observational studies using secondary data address the issue of 
endogeneity; therefore, conclusions depend on so-called “naïve” estimates such as results 
from ordinary least squares (OLS) estimations of the effect of health and nutrition status on 
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education outcomes13. After addressing the weakness of such studies, I will look at the 
studies addressing potential biases.  
The strength of quasi-experiment studies is that the mechanisms are analogous to 
experimental studies that ideally would eliminate the heterogeneity in unobserved variables 
by creating a counterfactual situation. Although in reality, such a counterfactual situation is 
not likely to be created due to violations in the original planned assignment. Some of the 
reviewed studies employ an exogenous shock measure as their instrument. Since such an 
exogenous shock is used as the instrument for a regressor, in the reviewed literature, health 
status in the early age, it overcomes the exclusion restriction which previous studies have 
often violated. As a result, the use of such exogenous shock corrects many of the 
shortcomings of results obtained from non-experimental studies. The summary results were 
presented in Table 6. 
 Grantham-McGregor et al. (2007) reviewed on cross-sectional studies in 
developing countries and conclude that there was an association between malnutrition and 
cognitive educational outcomes measured in cognitive score, IQ test, and reasoning and 
arithmetic and also in school grade attainment of children. Unfortunately, in their article, the 
                                                   
13 Alderman and others (2001) indicate that child health is three times as important for enrollment than suggested by 




authors specifically state “we do not assess causality”(p.63) (Grantham-McGregor, 2007). 
Although with the limitation for a causal inference, summarized results in their study showed 
the overall trend of the effect of malnutrition and education outcomes.  
Victora et al. (2008) performed an analysis using data from five long-standing 
prospective cohort studies from Brazil, Guatemala, India, the Philippines, and South Africa. 
Their analysis looked at how maternal and child undernutrition affected adult outcomes, 
including height, schooling, income or assets, offspring birthweight, body-mass index, 
glucose concentrations, and blood pressure (Victora et al., 2008). The status of child’s 
undernutrition was measured by birth weight, intrauterine growth restriction, weight, height, 
and body-mass index at two years according to the new WHO growth standards. Controlling 
for potential confounding variables such as age, parents’ educational level, and child’s 
socioeconomic status, the authors found that the strongest positive predictors of schooling 
was height-for-age and there was 0.5 increased years of schooling (p<0.01) with one unit 
increase in height-for-age.  
Jones et al. (2008) examined the association between household socio-economic 
status (SES) at birth and stunting of growth between South Africa and the Philippines. The 
data were from two longitudinal birth cohorts, the Birth to Twenty study in South Africa and 
the Cebu Longitudinal Health and Nutrition Survey (CLHNS) in the Philippines. While the 
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final data size was reduced due to limited number of observation especially in South Africa 
(n 2293 total; reduced to 450: stunting at 1 year) and 401 (stunting at 2 years) and CLHNS 
infants (n 2513 total; 1820 (stunting at 1 year) and 1710 (stunting at 2 years). The 
Philippines’ infants were significantly more likely to be stunted at 1 year (32.6 v. s.8.7%) and 
2 years (48.9 v.s. 21.1%) compared with South African children (Jones et al., 2008).  
The authors performed logistic regression analyses controlling for age and parity 
as covariates. The results showed that SES measures including maternal education, 
refrigerator and television ownership, and water and toilet facilities were significant 
predictors of stunting at one and two years of age in the Philippines’ cohort (OR 
0.61:0.53-0.70CI at age one and OR 0.51: 0.47-0.58 CI at age two) but not for those in 
South Africa.  
While the above-stated studies mostly did not have all of variables which should be 
included in the analyses neither look at a causal relationship between child’s unfavorable 
health status and education outcomes, there were some studies addressing endogeneity 
and seek for solutions to correct such a problem.  
Glewwe and Jacoby (1995) carefully examined a causal effect of malnutrition on 
education outcomes using cross-sectional data in Ghana. They investigated the relationship 
between malnutrition (height-for-age at preschool age) and delayed enrollment and 
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(ultimate) grade attainment on 1757 Ghanaian children aged 6–15 years in 1988–1989. 
They tried two approaches to account for endogeneity. The first was to use the family FE 
model. The underlining idea was that child health varies within families, but parental tastes 
for child health and education outcomes do not vary within the family. In this setting, within 
family correlation of child health and education outcomes should not be caused by any such 
correlation in parental tastes. More specifically, the parental tastes for child health and child 
education outcomes. The second strategy they use was IV approach. They used distance to 
nearby hospitals and maternal height as instruments. The IV method can be used when 
analyzing variation across households and not within households since these instruments 
do not vary across children in the same family. Therefore, these two approaches 
complement each other.  
The key assumption used the IV approach is that the distance to nearby medical 
facilities and the mother’s height affect child schooling only through their impact on child 
health status. Although the authors recognized the limitations of the two approaches, there 
were few critical points to be argued. The family fixed-effect approach does not take the 
variation in child genetic healthiness or variation of reallocation of unobserved education 
inputs across different children within the family. Failing to take this variation into account 
will lead both to an underestimate and overestimate of the effect of child health on education. 
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For example, if parents see a relatively sick child compared to his/her siblings in family, they 
may put more resources to sicker child. Or, they might decide to do the opposite, investing 
less in such a child’s education. Parents may treat children differently according to age, 
which is affected by family income cycle and parental experience with earlier children as 
well.  
For the IV approach, there was the strong assumption14 that the height of the 
mother and the distance to the nearest medical facility can affect child’s education outcomes 
only through child health. The distance to the nearest medical facility can be correlated to 
many community characteristics that may also affect education decisions such as access to 
school, other public facilities, and therefore, also affect school quality. It may also be 
affected by the degree of urbanization; and therefore, access to urban services and urban 
influences, which ultimately affected child’s education. Also the validity of using a mother’s 
height as the instrument was doubtful if we see the mother’s height as the health and 
nutrition status of her, then it could affect her productivity and it may result into household 
income as well. The mother’s productivity would also affect how she allocates resources on 
her child’s education. Although in their study, exogeneity of height-for-age was rejected but 
exogeneity of family income measured by per-capita expenditures was not rejected. When 
                                                   
14 Other assumptions for the IV approach will be discussed in Chapter 3 and 4. 
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treated as exogenous, family income had a significant impact on delays only.  
The authors found that strong negative impacts of child health measured through 
malnutrition on delayed enrollment using both the IV and FE estimators. With a decline in 
height-for-age of one, 0.634 month decrease in enrollment and the t-value is 2.49. 
Unexpectedly, they found no statistically significant evidence that child health increases 
school attainment as measured by grade completed.  
Other studies that used a cross-sectional data are at a disadvantage, since the 
current health condition is greatly affected by the past health status. The result of measuring 
only current health status and estimate the impact on education outcome may result in 
positive and statistically significant results. In fact, the problem of endogeneity permeates 
not only in cross-sectional studies but also in longitudinal studies. In the next sub section, I 
will review recent studies that use longitudinal data.  
Glewwe, Jacoby, and King (2001) used panel data from 2,192 households in the 
Philippines. Height-for-age was measured at age 8 and unlike the other studies focusing on 
the quantity of education outcome and education outcome was measured by test scores 
(Glewwe, Jacoby and King, 2001). They use two approaches as Glewwer and Jacoby 
(1995) used in their early analysis on Ghana. The use of family fixed effect removed family 
averages of innate academic ability and all school quality variables since the siblings in the 
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same household go to same school. They also used an IV approach to address remaining 
endogeneity and use the height of the older child at age 24 months.  
The same arguments made for the Ghana study could be also applied here. It was 
intuitive to see the decisions of resources allocation on health investment and also on 
educational inputs could be influenced by differences in innate ability among siblings in the 
same family, which may lead to correlation between early childhood health investments and 
primary school test scores. However, the authors argued that health investments made until 
child’s 24 months of age could not be correlated with innate child academic ability. They 
referred to psychology studies that conclude that parents cannot observe children’s innate 
ability until the child is older than 24 months; therefore, it was assumed to be uncorrelated to 
health investment made by their parents. This was a very strong assumption to make but 
was needed in order to deliver the economic identification.  
The authors also argued that the impacts of parental education inputs before the 
child reached primary school age and the impacts of current child health status on primary 
school academic scores were negligible so they could be dropped from that equation. On 
the condition that parents could not see the children’s innate ability until the child was older 
than 24 months, they used the height of the older sibling by age 24 months as the 
instrument for height-for-age. Although they made strong assumptions to make their 
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estimation strategy more credible, the assumed conditions were unrealistic.  
The most unrealistic assumption was that health investments made from 
conception through 24 months of age cannot be correlated with innate child academic ability 
because parents do not observe children’s intelligence until after the child reached at least 
24 months of age. Many parents believe that the education inputs such periods have strong 
impact on later cognitive outcomes. With limitations of the estimation strategy explained 
above, the authors concluded that children’s health status measured by height at age 8 had 
strong impacts on their test scores. They found that a one standard deviation increase in 
height-for-age raises the achievement test score by 8.9 (t=2.8) points. They also show that 
such direct effect of nutrition on learning productivity per year of school was equivalent to 
spending about eight extra months in school. 
 Alderman et al (2001) used panel data collected for 800 households from 1986 to 
1991 in Pakistan. They used height-for-age at 5 years old and education outcome was 
measured by the probability of being enrolled in school at age seven school enrollment. In 
order to correct the endogeneity problem of health status, they used food prices as an 
instrument, which captured the deviations in prices from long-term trends obtain unbiased 
estimates.  
 Their study had several potential limitations. First, they did not control for 
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household heterogeneity. Since the IV method can be used when analyzing variation across 
households not within household, the variation within family was remained as untreated. 
The use of food price shocks in the first time period as IVs for health status in that time 
period was theoretically valid only if price shock affected education outcome only through 
the health status of that time periods. However, since they included an initial wealth variable 
as covariates, household expenditures averaged over three years which included those on 
educational inputs, given price shock was more likely to affect the spending on education as 
well. 
Moreover, the price shock in the first time period also affected parents’ behavior on 
resource allocation on child’s education in the second time period by changing savings. 
Therefore, the use of price shock in the first time period potentially violated the exclusion 
restriction. With several limitations, their results suggested that the effect of height was 
significantly and substantially greater for girls than for boys. The results were seven times 
larger for girls than for boys (0.51 with SE=0.14 for girls; 0.07 with SE=0.18 for boys).These 
results were equivalent to an improvement of 0.25 in height-for-age score raise, the 
probability of school enrollment for girls by 9 percent over the base case and for boys by 2 
percent. 
The Institute of Nutrition of Central America and Panama (INCAP) study (Pollitt et 
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al., 1993) focused on the relationship between a high protein diet and education outcomes. 
It was initiated in four Guatemalan villages in 1969, two of which were randomly selected to 
receive a porridge (atole) that was high in calories and protein while the other two villages 
received a drink (fresco) with less calories and no protein. Follow-up studies over the next 
two decades appear to show sizeable effects on later cognitive outcomes from providing the 
atole to mothers and young children.  
Focusing on the effect of child’s health on education outcomes, Maluccio et al 
(2006) evaluated the middle-long term impact of nutrition supplement intervention in 
Guatematra. The attrition rate was relatively low because they set certain criteria15 for 
inclusion for the follow-up study, there were 1,090 individuals (46 percent of the original 
sample and 54 percent of those alive in 2007) from the original sample and 1,463 children of 
original sample members. The exposure period chosen by the authors was defined as the  
period from birth to 36 months of age, based on earlier research with the 1969–77 data. For 
education outcomes, they used grade attainment, reading comprehension and non-verbal 
skills.  
Maluccio et al. employed the DiD16 approach, the village fixed effect and the IV 
                                                   
15 These criteria are who 1) were interviewed successfully 2) were living in one of the original study villages 3) had 
a biological parent living in the area 
  
16 However, in their estimation strategy, only one reduced-form equation is written, the detail use of 
difference-in-difference is not specified clearly.  
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(exposure to atole as the instrument) to account for potential biases. The village fixed effect 
to capture all fixed characteristics of four villages that might affect education related 
outcomes. It was crucial to include these because of the small number of villages in the 
experiment. The village fixed effect could capture persistent cultural differences and fixed 
differences in educational or economic opportunities that might have resulted in different 
educational investments across villages even without the interventions. Maluccio et al also 
controlled for other confounding variables including gender, birth year of a child, parents’ 
age when child was born, parents’ educational attainment, household wealth, and the 
distance to feeding center. In addition, the authors constructed community-level covariates 
that related to key education-related decisions in a child’s development. Those were 
indicator variables of the availability in the village of a permanent (cement-block) structure 
for the primary school when the respondent was seven and 13 years old (supposedly the 
time children enter primary school and secondary school), and primary school 
student-teacher ratios when the respondent was seven and 13 years old. This accounted for 
the time-variant characteristics of community and school. Their results showed that female 
schooling increased by 1.17 grade (t=2.13). Both female and male reading comprehension 
were increased by 0.28 scores (t=2.52) which was equivalent to about one-quarter of a 
standard deviation. Also for both female and male non-verbal skills were increased by 0.24 
52 
  
scores (t=2.01) which was also equivalent to about one-quarter of a standard deviation.  
In the INCAP study, sample attrition was a major concern in the 1988–1989 
follow-up, as 40% of the original sample was not included in the final analysis. The attrition 
in the sample might have been associated with a number of initial conditions and 
characteristic of that individual or household that affected health status and education 
outcomes, which depends on whether attrition was random or non-random and whether 
sample size was large enough for power tests. In order to account for the attrition bias, 
sensitivity analyses, they used the results from census data which included the same 
individuals from the original study and covered 90% of the original sample. Using this village 
census-based sample, the estimated effects of atole on grades attained were remarkably 
similar to those based on HCS, including the exact same set of controls.  
The study by Linnemayr and Alderman (Linnemayr and Alderman, 2011) used data 
from the two survey rounds (2004 and 2006) of the Senegal Nutrition enhancement program 
which was included to provide participants with vitamin A and deworming for children 6–59 
months, iron for pregnant women, bednets, breastfeeding promotion, cooking workshops 
and implemented from 2004 to 2006. The authors used weight for age as the measure for 
child health status, which tends to indicate not only a child’s health status in the long-term, 
but also the short-term. This could be problematic since this measure did not allow for the 
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isolation chronic and acute nutrition status, and possible factors that might have affected 
one and not the other. However, in this study, a serious selection bias existed. The result 
showed that of the 111 villages that were initially assigned treatment status, 80 ended up 
receiving treatment, while 31 villages (28%) did not receive the intervention. Of the 100 
initial control villages, 8% received the intervention despite their control status.  
Linnemayr and Alderman used the IV, DiD and PSM techniques to account for 
potential biases due to the imperfect execution of random assignment. As the instrument, 
they used “planned treatment status”. Such a variable was exogenous by construction, and 
was also a strong predictor of actual treatment. In the first stage of analysis, planned 
treatment status and other village-level variables were used as instruments for actual receipt 
of the intervention. In addition, they included initial village-level characteristics such as 
distance to the next village, prevalence of female education, or the presence of a market 
that may have influenced the NGOs' placement decision as well as five interactions of 
village characteristics and the planned treatment. The result of the IV estimation, however, 
showed the insignificant effect of program actual implementation. The estimator based on 
the combination of PSM17 and DiD findings showed a statistically significant result at the 5% 
level and about a 0.27 standard deviation increase in weight-for-age score.  
                                                   




 While the results of the IV analysis showed no significant effect on the intervention, 
the result from the PSM and DiD analyses appeared to be significant. It might be the case 
that since the baseline used in the DiD analysis is in the absence of treatment, both groups 
would experience a similar trend in the outcome variable; in other words, the time trend of 
the treatment group and comparison group were the same, and there were unobserved 
time-varying characteristics affecting the results. Also the PSM technique used estimates 
based on the observed characteristics, and therefore, remaining unobservable differences 
might have still leaded to a biased estimation of treatment effects. However, The IV estimate 
may have absorbed those remaining unobserved characteristics. Unlike the follow-up 
evaluations for the health targeted intervention, the following studies emploed a shock 
measure such as exposure to war and natural disasters as their instruments.  
Alderman, Hoddinott, and Kinsey (Alderman, Hoddinott and Kinsey, 2006) 
estimated the effect of preschool height on years of completed schooling and delayed 
enrollment in Zimbabwe. The data consisted of a sample of 665 Zimbabwean young adults 
in 2000, which was a follow-up to two earlier surveys of children carried out in 1983-1984 
and 1987. The authors linked exposure to transitory shocks experienced by children before 
age three to their pre-school nutritional status, as measured by height-for-age. Education 
outcomes were as measured as a number of grades attained and the timing of starting 
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school. Using the combination of maternal FE and IV estimation to showed that exposure to 
civil war and drought shocks in early childhood in Zimbabwe, the results suggested that 
reduced height-for-age, which subsequently had a negative impact on years of schooling 
and adult height. In addition, exposure to civil war and drought were associated with 
decreases in child height-for-age by 0.049 (t=3.17). The result of maternal fixed effect and 
IV estimates showed that improvements in height-for-age in children under five leads to 
increased height as a young adult, and an increased number of grades of schooling 
completed by 0.678 (t=2.13) as well as being causally associated with starting school at a 
younger age (0.400 (t=1.65)). Over-identification tests confirmed that these instruments did 
not violate the exclusion restriction.  
The previously reviewed studies have separated the impact of child’s nutrition 
status on schooling from other factors that determine schooling and nutrition status, 
however the latent problem these studies had was that they did not take into account the 
importance of early childhood health status. The measures for health used in their studies 
were after the critical development periods, roughly from age zero to two. Alderman, 
Hoogeveen, and Rossi (Alderman, Hoogeveen and Rossi, 2009) examined the effect of 
early child’s malnutrition on delayed school entry and the total years of schooling attainment 
using a panel data set that combine the 2004 Kagera Health and Development Survey 
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(KHDS) with all individuals who were household members of the KHDS 1991-1994.  
They measured health status as height-for-age for children under ten years old in 
1991-1994 thus including the critical periods of child’s development. However, in order to 
account for the non-linearity of the impact of nutrition on education output, they used a 
quadratic form of height which is measured as a percentage of the median of the reference 
population18. This made interpretation of their results very convoluted. Education outcomes 
were measured as delayed enrollment defined as a child had not entered school at the age 
of 7 and years of schooling at the second round.  
They used community fixed effect to rule out the possibility of bias from 
unobserved community level effects including infrastructure. They used crop loss happened 
in 5-6 years prior to the first round interview for controlling for household level characteristics 
and whether shock experienced 5-6 years prior to the interview for the community level 
characteristics as the instruments for height-for-age and these variables were interacted 
with age 0-3 and 4-5 and gender (see the same approach taken by Alderman Hoddinott and 
Kinsey 2006).  
Over-identification tests confirmed that these instruments did not violate the 
exclusion restriction. With the same limitation applied to Alderman et al (Alderman et al., 
                                                   
18 The authors take 85% of the median as reference height because stunted children exhibit, on average, a value of 
height which is equal to 85% of the reference median. 
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2001), not controlling for the variation within household, their results suggested that one unit 
increase in height-for-age as a percentage of the median of the reference population 
percentage decrease 0.591(z=3.42) delayed enrollment and one unit increase in 
height-for-age as a percentage of the median of the reference population increased the 
0.575 years of schooling (z=2.18). However, these results did not give us any intuitive 
understanding of what these numbers meant. Making attained results more relevant in 
terms of change in height-for-age, the authors run simulation for the results and showed that 
if the height of a boy was increased from 80% to 95%19 of the median, this would increase 
schooling by 0.93 years, while the increase was 0.85 years for boys whose height was equal 
to 85% of the median. In fact, although not shown in the paper, these results were similar to 
the results for OLS which were the years of schooling for boys at 85% median is 6.9 and 
7.05 for 90%20. 
In recent years, several new longitudinal studies have investigated the effect of 
childhood malnutrition on education outcomes such as school delayed school entrance, final 
grade attainment and test score (Victora et al., 2008; Jones et al., 2008; Glewwe and 
Jacoby 1995; Glewwe, Jacoby, and King 2001; Alderman et al., 2001). Few results from 
                                                   
 
20 The reason for this is that they include rich covariates in their OLS regression. The covariates in the analysis 
include age of child, gender, household expenditure, parent having secondary schooling, maximum grade of parents, 
heights of parents, school quality as indicated by both teacher pupil ratio and boards per class, urban or rural, and 
access to electricity. 
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quasi-experiments which employed a shock measure as exposure show that increased 
health status of a child had a causal effect on education outcome such as delayed 
enrollment and final grade attainment (Alderman, Hoddinott, and Kinsey 2006; Alderman, 
Hoogeveen, and Rossi 2009, Linnemayr and Alderman 2011). Earlier studies using 
cross-sectional data had already shown that an increasing level of stunting shows negative 
association to education outcomes (Grantham-McGregor and others 2007, Glewwe and 
Jacoby 1995).  
In order to address endogeneity, the most of these studies used FE approach to 
control the unobserved household characteristics which do not change over time and do not 
interact with variables that do change over time. The IV method was used to account for the 
bias due to correlation of the observed variables with that error term other than household 
characteristics. A combination of two approaches seems valid only if household unobserved 
characteristics such as parental teats do not vary within same household.  
In a quasi-experimental design, in addition to the IVFE approach, DiD and PSM 
were used in the reviewed literature. Since previous literature used an exogenous shock 
measure, the results were more likely to estimate a true effect size. However, for the studies 
with the initial program intervention, the common problem with randomized trials was that 
there was a departure from the initial design which ultimately biases the results. Especially 
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an adherence to originally assigned treatment status became increasingly difficult in reality. 
The results from these empirical studies controlling for endogeneity are consistent in the 
sense that improved child health, as captured by height, appeared to have a large positive 
causal impact on education outcomes. However, once controlling for range of covariates, 
the results attained from “naïve” estimates show the very similar results as improved 
estimates accounting for endogeneity (see Alderman, Hoogeveen, and Rossi 2009).  
 
2.4. Conclusion  
The association between the timing of the Kasai procedure and survival of native 
liver has been suggested in many studies; however, these studies did not fully account for 
unmeasured confounding.  
Three studies (Lien et al., 2011; Chardot et al.1999,; Chardot et al., 2013) 
conducted multivariate analyses, and in their studies, the early timing of Kasai procedure 
was associated with better prognosis.  
Yet, none of the previous literature focused on the threshold of the timing or the 
causal effect of the Kasai procedure. The possible categorization for the timing of Kasai 
procedure will be less than 30 days and added up by 15 days since the earlier intervention 
seemed to larger impact on the later outcomes in France study with the largest sample size 
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in the existing study (Chardot et al 1999, 2013). T  
The review on the literature on investigating the causal effect of health on 
education revealed that many of previous studies in economics and education have used 
the quasi-experimental techniques such as IVFE approach, DiD and PSM to address the 
potential biases in observational studies. The most of these studies used a FE approach to 
control the unobserved household characteristics which do not change over time and do not 
interact with variables that do change over time. The IV method was used to account for the 
bias due to correlation of the observed variables with that error term other than household 
characteristics. A combination of two approaches seemed valid only if household 
unobserved characteristics such as parental teats did not vary within same household.  
By adapting the methodologies developed and used in economics and education, I 
will estimate the causal effect of the timing of the Kasai procedure on patient outcomes. In 
order to apply the methodologies used and developed in economics and education into the 
causal analysis of the timing of the Kasai procedure in BA study, in the next chapter, I will 






The goal of this dissertation is to provide comprehensive evidence on the effect of 
the timing of the Kasai procedure on patient outcomes. Since none of previous literature has 
focused on the causal effect of the timing of the Kasai procedure on patient outcomes or 
trying to control for rich sets of covariates21, this study will shed lights on many important 
features of BA that have not been fully addressed before.  
My main interest is: ‘what is the expected outcome to patients by change in the 
timing of the Kasai procedure relative to the counterfactual situation?’ The focal point of the 
question is to identify the factors that contribute to variation in the timing of Kasai 
procedures in infants with BA.  While the randomized control trial is considered the gold 
standard for the evaluation of the effect of a particular treatment on patient outcomes, in 
many settings (including the one presented with my research question), it is impractical and 
unfeasible to measure outcomes in a complete “counterfactual” scenario, as a strict 
treatment assignment is difficult to pursue. Since the negative relationship between the 
delayed the Kasai procedure and prognosis has been previously suggested (Lien et al., 
                                                   
21 See Chapter 2 
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2011; Chardot et al.,1999; Chardot et al., 2013), the designing randomized controlled trial is 
not the most desirable way to evaluate the causal effect of the early operation of Kasai.  
Many previous studies in economics and education have developed 
quasi-experimental techniques to address the potential biases in observational studies. 
Since the strength of this study is that the data with the largest number of subjects in the 
world, 2743 patients allowed overcoming the limitations with the small sample size, which 
many of previous studies encountered.  
In order to understand the potential biases and approaches to overcome these 
biases, it is important to understand the foundation of causal inference and threats to causal 
inference, particularly the issue of selection bias and endogeneity in observational studies. 
After describing the potential biases, I will suggest four statistical approaches that could 
potentially mitigate the effects from such biases.  
 
3.2. Foundation of Causal Inference 
Angrist et al. (Angrist, Imbens and Rubin, 1996) explained that causal inference in 
statistics evolved from work by Fisher (Fisher, 1919) on agricultural experiments. Fisher’s 
work on the basic formulation of causal inference was then extended by Rubin (Rubin, 
1974) providing greater emphasis on more complicated scenarios such as those which were 
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often the focus in observational studies without randomization. This approach is now widely 
used, and is typically referred to as either the potential outcome approach, or the Rubin 
Causal Model (Holland, 1986). In the basic form of this model, there are two potential 
outcomes (YT, YC) for each individual, where YT indicates an outcome of an individual who is 
assigned to the treatment (such as an early the Kasai procedure) and YC indicates the 
outcome of a similar person without a given treatment. Further we define a binary 
assignment indicator D, indicating whether an individual actually received the given 
treatment (D = 1) or not (D = 0). The treatment effect for each individual is then defined as 
the difference between potential outcomes: 
Δ = YT - YC--- (1) 
As described in equation (1), the causal effect of the treatment on a targeted subject is the 
difference between the outcome under treatment and without treatment (the counterfactual 
scenario). The fundamental problem of causal inference persists in the fact that the outcome 
cannot be observed for both situations for the same individual. Instead, the average of the 
entire sample is taken, and the quantity is noted as:  
E(YT - YC) --- (2) , and called Average Treatment Effect (ATE)  
In the experimental settings, individuals are assigned randomly to a treatment 
group or control group. Successful randomization allows us to see the pure effect of the 
treatment on those who are assigned to the treatment can be estimated through the 
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evaluation parameter, ‘average treatment effect on the treated’. It ensures statistical equality 
of observed and unobserved characteristics, and is therefore independent from potential 
outcomes and assignment to the treatment. The assumption that the treatment effect Δ in 
equation (1) for each person must be independent of the treatment of other individuals and 
this is called the stable unit treatment value assumption (SUTVA). The parameter for 
estimating the population average of gains from treatment is the so-called ‘average 
treatment effect on the treated’: 
E (Δ| D = 1) = E (YT| D = 1) – E (YC|D = 1) --- (3) 
It could only answer the question of ‘what is the expected or mean outcome gain to 
individuals who received treatment to the hypothetical situation had they not received it?’ 
The second term in (3) is the hypothetical outcome without treatment for those subjects who 
received treatment. If the condition 
E (YC |D = 1) = E (YC |D = 0) --- (4) 
holds, then the non-assigned patients can be used as a control group. The 
above-mentioned condition is the ideal situation where there is a random allocation in which 
to take part. However, when randomization is not possible, there are threats to causal 
inference, and therefore the ability to assess the real effect of the intervention is in question. . 




3.3. Threat to Causal Inference 
In a real-world setting, there are many situations where it could be harmful to 
assign or not assign a given medical intervention, or it could be the case that the 
considerable cost of designing and implementing a randomized controlled trial would make 
such a study unfeasible.  
 
3.3.1. Experimental Study  
Selection bias occurs when study subjects self-select into either the treatment or 
the control group based on certain characteristics (or physicians select patients due to 
particular characteristics). Some patients take the treatment because it is believed their 
response to the treatment is quite large, whereas those who do not take the treatment have 
either minimal response or even a negative response to the treatment. If there is 
heterogeneity in the response to the treatment, the calculation E (YT| D = 1) - E (YC |D = 0) is 
insufficient  to estimate the effect of the treatment. The randomization design does not 
remove such selection bias, but balances it between the treatment and control groups, 
effectively cancelling out its impact on the observed treatment effect. Randomization 
ensures that, on average, both groups are statistically equivalent in both observed and 
unobserved characteristics, and therefore, the potential outcomes are independent of the 
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assignment to the program. However, as stated above, randomized control studies are not 
always feasible in social science settings, and therefore the causal effect of the treatment 
cannot be calculated as described in equation (1). Instead, the observed outcome for each 
individual is given by: 
Y = D ∗ YT + (1 – D) ∗ YC --- (5) 
Equation (5) shows that the two potential outcomes, YT and YC, cannot be 
observed for the same individual simultaneously. The unobservable component in (5) is 
called the counterfactual outcome, so that for individuals who took the treatment (D = 1), YC 
is the counterfactual outcome, and for those who did not (D = 0) it is YT. In this setting, the 
problem of evaluating the individual treatment effect can be interpreted as a missing data 
problem because for any given individual the counterfactual outcome cannot be estimated. 
However, there are limitations to non-randomized study designs, as there are situations 
where it appears one cannot actually measure both YC and YT at the same time. 
 
3.3.2. Observational Study  
The latent problem of selection bias persists more in non-experimental studies 
since these studies do not allow such random assignment to occur. In addition to the 
selection bias, it is more likely that the observed independent variable and explanatory 
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variable are correlated with unobserved or confounding variables influencing both the early 
Kasai procedure and outcomes in observational studies. This problem is referred to as 
endogeneity, and this can become a problem in a typical empirical model. The simple linear 
approximation of the effect of early Kasai procedure on patient outcomes can be expressed 
as:  
p(SNL) i = β0 + β1 Ki + β2 Xi +α+ µI --- (6) 
where SNL i is a survival with native liver, Ki is the early Kasai procedure , Xi is a set of a 
vector of other inputs that influence survival of native liver, α is the child’s innate healthiness 
that would account for the severity of the disease, and µi is a normally distributed error term. 
The term β１ is interpreted as the effect of “early Kasai procedure” on outcomes of patients. 
In observational studies, the problem arises when there are unobserved factors that affect 
both the survival with native liver and the timing of Kasai. It is the nature of rare disease that 
there are many unknown factors that might affect both the predictor and the outcome. In 
addition to such uncertainty, there would be “potentially observable” characteristics but not 
taken as variables therefore not in the analysis. Such important determinants may include 
any characteristics relating to the sociodemographic and socioeconomic status of patients, 
as well as environmental (geographic and seasonal), clinical, hospital and other potential 
factors such as the characteristics of each local government providing or influencing health 
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services for childcare.  
Much of the available literature has focused on the clinical characteristics of 
patients in relation to the timing of the Kasai procedure and outcome. For example, types of 
obstruction (Nio et al., 2006) and existence of malformation (Shneider et al., 2006; Dillon et 
al., 1994; Davenport, 2006; Schwarz et al., 2013) were proven to be predictors for later 
improved prognosis. For the hospital characteristic, it appeared that a center that performed 
at least five the Kasai procedures per year had a better success rate, as measured by 5- or 
10-year long-term survival with the native liver (Davenport et al., 2011; Chardot et al., 1999). 
However, the results noted above come from studies that did not fully control for any 
potential confounders. While certain potential confounding factors may not have an obvious 
influence on short-term outcomes, they may prove to be pertinent later.  
Other characteristics could include the local government’s involvement or influence 
on the provision of child health services in general, which could vary substantially, 
particularly in Japan. Some local governments provide home visiting by nurses to check the 
general healthiness of infants and mothers at one month after a delivery. Since the early 
detection of BA is largely depending on catching the early symptoms such as persistent 
jaundice, home-visiting by medical professional might influence the early detection leading 
to the earlier the Kasai procedure. Also as explored in the previous studies, geographic and 
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seasonal variation might affect the outcomes as well.  
 The innate healthiness of a child, α in the basic model, is difficult to measure. 
Although often birth weight is used as a proxy for the innate healthiness in more general 
settings when investigating the effect of health on educational outcomes, for the case of BA, 
which is more disease-specific, the use of birth weight as a proxy for the innate healthiness 
might be misleading because patients are usually born at full term. Measuring motivations 
among medical staff and parental characteristics on the management of the whole process 
are very difficult in reality. Also parents’ focus on a child and ability to manage the 
pre-and-post operation are difficult to measure as well. There are both observed and 
unobserved processes that lead to determining the timing of the Kasai procedure, and these 
factors are correlated with survival with native liver, either directly or indirectly.  
 
3.4. Empirical Approach to the Problems of Selection Bias and Endogeneity 
After briefly explaining the traditional logit regression approach, both weakness 
and strengths of four approach will be disused. These approaches will be DiD, PSM, FE and 




3.4.1. Logit Regression: The Basic Model  
The following shows the basic empirical model to estimate the effect of early Kasai 
intervention on the outcome:   
log(p/(1-p))SNL kt  = α0 +β1Kkt + β2Xkt +αkt+εkt --- (7) 
where SNL kt is a probability of survival of native liver at t (1-, 5-, 10-, 15-, and 20-year) with k 
individual. Kkt is the timing of the Kasai procedure. Xkt is a vector of other inputs that 
influence survival of native liver. According to the previous studies, anatomic pattern (Nio et 
al., 2006), existence of malformation (Shneider et al., 2006; Dillon et al., 1994; Davenport, 
2006; Schwarz et al., 2013), and expertise of the surgeon and care center had strong 
associations with the outcome (Dillon et al., 1994; Davenport, 2006). These characteristics 
should be included in Xkt. The error term εkt captures unmeasured variables.  
Although in this study, rich set of covariates including anatomic pattern, existence 
of malformation, and expertise of surgeon and care center, there still would be a latent 
problem of omitted variables. αkt indicates the child innate “healthiness” that would affect the 
progress and severity of the disease. While various sociodemographic and clinical 
characteristics available in this study and these might be partially able to represent the 
innate healthiness, realistically it is very difficult to control in the model. There is potential 
bias in this model due to possible correlation between Kkt and εkt resulting from any 
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correlations between sociodemographic, socioeconomic, clinical, and hospital 
characteristics in addition to child’s innate healthiness. However, this potential bias can be 
corrected for by using IV and FE techniques. 
In multivariate logit regression, it is assumed there is no left-out variable or 
confounding variable that may bias the estimates associated with the effect of the timing of 
the intervention, in this case, the effect of a Kasai on patient outcomes. If this condition does 
not hold, then the estimates of Kkt using the logit regression will be biased. But in reality, it is 
always difficult to include all possible covariates in a model. In order to mitigate such bias, 
DiD, PSM, FE, and IV have been used in the previous studies performed in other settings to 
see the effect of health on education.  
 
3.4.2. Difference-in-Difference  
Linnemayr and Alderman (2011) use DiD and PSM in their analysis. The DiD 
approach can generate a reliable estimate in scenarios where there is a natural experiment 
such as a sudden policy change. The DiD estimation method can be interpreted as an 
extension to the classical before-after estimator. In order to compare the differences 
between before and after, we need have a “shock” measure, which acts like an intervention 
in the experimental design. Using “exposure to shock” as a health shock that acts like an 
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intervention in a natural experiment, DiD estimates the effect of such “shock”.  
In order to apply this technique, it is necessary to have data on pre and post 
exposure covering both those who are exposed and those who are not, as well as one or 
more additional follow-up surveys after the exposure. The following table (Table 8) 
represents the steps necessary to estimate a DiD estimator. There are four data points, 
namely pre-exposure (t0) data points (Yt=0 and Ct=0), and post-exposure data points (Yt=1 
and Ct=1). The difference of differences between pre- and post-data points is DiD estimator 
((Yt=1 - Yt=0) – (Ct=1 – Ct=0)).   
Table 8: Calculation of DiD 
 Exposed group Control Group Difference across groups 
T1 Yt=1 Ct=1 Yt=1 - Ct=1 
T0 Yt=0 Ct=0 Yt=0 – Ct=0 
Difference 
Across time 
D1: Yt=1 – Yt=0 D2: Ct=1 – Ct=0 DiD: (Yt=1 – Yt=0) – (Ct=1 – Ct=0) 
 
 The assumption needed for DiD estimator is that the time trend of the treatment 
group and comparison group is the same. In order to assure that the comparison group is 
similar to the treatment group before doing the double difference, often the PSM method is 
used.   
Recall Eq (7) which is rewritten as:  
log(p/(1-p))SNL kt  = α0 + β1Zk + β2Tk +β3ZkTk +β4Xkt +εkt ---(8) 
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where Zk denotes exposure group (living in area affected by shock or not) and Ti denotes 
time period (pre- and post-redistricting). ZkTk is an interaction, which measures precisely the 
differences in means across two levels of a dummy variable for the only observations that 
actually get exposed.  
 In my analysis, the implementation of stool color cards was intended to be included 
in this analysis because it stands as a shock measure. The national color card screening 
was launched in 2012 and prior to that there were 10 regions in Japan where implemented 
the introduction of a stool color card. The necessary data for this technique was data on pre 
and post exposure, which must cover both those who were exposed and those who were 
not, and one or more additional follow-up surveys after the exposure should be in place. 
Recall Eq (8), where Zk denotes the exposure group (living in an area where a pilot 
screening was implemented) and Ti denotes the time period (pre- and post-pilot studies; 
1=before year X 0=after year X). ZkTk is an interaction, which measures precisely the 
differences in in means across two levels of another variable that is a dummy variable for 
the only observations that actually get exposed (born before/after or patients who lived in 12 
regions in Japan after year X). 
 
3.4.3. Propensity Score Matching 
Linnemayr and Alderman (2011) used PSM to assure that the comparison group is 
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similar to the treatment group before applying the double difference approach, (as explained 
in the previous sub-section).   
Recall Eq (1), there are two potential outcomes (YT, YC) for each individual, where 
YT indicates an outcome of an individual who is assigned to the treatment, and YC indicates 
the outcome of a similar subject without a given intervention. Further, a binary assignment is 
defined as D, indicating whether an individual actually participated in an intervention (D = 1) 
or not (D = 0). Rosenbaum and Rubin (1983) suggested selecting a propensity score at 
random from the sample, then matching two individuals with this propensity score (one who 
chose treatment and one who did not), and constructing their outcome difference as:   
YT - YC-|p (X)---(9) 
If the condition	 E (YC |D = 1) = E (YC |D = 0) --- (4) folds the expected difference is  
E(YT - YC|p (X)) Average Treatment Effect (ATE) conditional on p (X).  
This assumption is called conditional independence assumption or ignorability. In other 
words, E(YT - YC|p (X)) is conditional on the observable set of confounders, and there is no 
selection bias based on unobserved heterogeneity. If this strong assumption holds, then the 
two potential outcomes are independent of the assignment to treatment, conditional on X. 
Although, this is a strong assumption and has to be justified by the data quality at hand. The 
propensity score can be calculated by using a standard logit or probit model, where the 
outcome is the treatment indicator, and the predictors are all observable variables. It can 
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occur that controlling for selection on observables may not be sufficient since remaining 
unobservable differences might still lead to a biased estimation of the treatment effect. The 
ideal data required for this method would include a large number of subjects and with more 
variables to facilitate good matching.  
 
3.4.4. Fixed Effect  
The fixed effect method is also used frequently in combination with the use of IV in 
the reviewed literatures (Alderman and others 2006; Maluccio, Hoddinott, and Behrman 
2006; Behrman and others 2006; Glewwer and Jacoby 1995, 2001).  In this study, the 
question is ‘what is the effect of timing of the Kasai procedure on patient outcomes?’ 
Intuitively, to estimate this effect, one has to account for the fact that hospitals might differ in 
characteristics. More specifically, the expertise of surgeon among other characteristics of 
each hospital would certainly result in positive or negative correlations between the timing of 
the Kasai procedure and outcomes that are not directly causal. 
Recall the equation (7), I can estimate the parameter τ from the regression:  
log(p/(1-p))SNL kt  = α0 +β1Kkt + β2Xkt +τZkt + γk t εkt --- (14) 
where E(εi|X1, …, XK, γ, Z) = 0. Since γ indicates unmeasured covariets, it is impossible to 
include in the equation. The possible solution for this is that suppose we observe X1, …, XK, 
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Z for two (or more) “paired” observations with the same value of γ. To be concrete, suppose 
there are 2n observations. Unlike the case above, there is no need to estimate a separate γ 
parameter for each unit, just for every pair of units. When the number of paired observations 
exceeds the number of covariates, it is possible to estimate all the model parameters. The 
hospital component (hospital fixed effect) and are of residence (geographical fixed effect) 
are possible candidates.  
There are limitations associated with the FE method, as seen in Glewwe and 
Jacoby, that FE cannot counted for variations in innate child healthiness or random shocks 
to timing of the Kasai procedure among patients within the same hospital. FE model controls 
variations within hospital. The previous literature has suggested using both FE and the IV 
because IV complements FE by controlling for variations across hospital. This combined 
approach has been applied by many researchers (Alderman and others 2006; Maluccio, 
Hoddinott, and Behrman 2006; Behrman and others 2006; Glewwer and Jacoby 1995, 
2001).  
 
3.4.5. Instrumental Variable  
The IV approach relative to logit regression, DiD, PSM and FE, which do not 
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control for unmeasured confounding is that IV approach could potentially provide a way to 
control for unmeasured confounding. Many of reviewed studies examining the effect of 
health on education used the IV approach (Alderman and others 2006; Maluccio, Hoddinott, 
and Behrman 2006; Behrman and others 2006; Glewwer and Jacoby 1995, 2001).  
Idealistically, since the timing of Kasai procedure (Kkt) might be endogenous, we 
can get an IV estimate of β1as: 
b1IV= Cov(y, z) = Cov(α0 +β1K + ε, z) = Cov(K, z) β1+Cov(ε, z) --- (10) 
     Cov(K, z)    Cov(K, z)           Cov(K, z) 
If the assumptions are correct about the instrument z, then Cov(ε, z) = 0, and therefore: 
b1IV= Cov(K, z) β1+Cov(ε, z) =β1 --- (11) 
Cov(K, z) 
So the IV estimator will be an unbiased estimator β1. Using this IV, the first stage in the 
two-stage least square (2SLS) is given by: 
1st Stage: Kkt = γ0 + γ1zkt + υkt ---(12)  
where Kkt is a regressor: timing of the Kasai procedure, and z is an IV. In Eq (12), it fits an 
OLS regression model to the hypothesized relationship between K and z as where the 
first-stage parameters γ0 andγ1 represent the requisite intercept and slope, and υkt is the 
first-stage residual that contains that part of question K that remains unpredicted at the first 
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stage. After obtaining the required predicted values from the first-stage fit, the second stage 
of the 2SLS becomes: 
2nd Stage: pSNLkt = α0 +β1𝐾kt + β2Xkt + εkt ---(13)   
There are certain assumptions that allow for validation of the instrument that 
randomizes observable characteristics relevant to the outcome. This suggests that they are 
expected to also randomize unobservable confounders. Angrist et al. (Angrist, Imbens and 
Rubin, 1996) considered an IV to be a variable which satisfies five assumptions: SUTVA, 
the IV is positively correlated with treatment assumption, the IV is independent of 
unmeasured confounders assumption, the exclusion restriction assumption, and the 
monotonicity assumption. The SUTUVA assumption states that there are no different 
versions of the treatment that have different effects and there is no interference between 
units. Also the last monotonicity assumption states that a hypothetical change in the 
instruments either has no impact on a unit’s treatment status, or changes its treatment 
status in the same direction as it does for all other units for which it has an impact. 
Monotonicity is also plausible in this study that the encouragement (Z =1) provides a clear 
incentive to take the treatment. Among five assumptions, the core assumptions of IV are 
depicted in Figure 7 which I will also be carefully examined in Chapter 4 as well. 
Firstly, the correlation between zkt and K must be non-zero in the equation (13). In 
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other words, the instrument must be related to the potentially endogenous question 
predictor. In Figure 7, it is expressed as the arrow from Z to D. The second important 
condition that must be satisfied for successful IV is that the IV is not associated with 
variation in unobserved variable. zkt is uncorrelated with εkt in the equation (13) and it is 
represented by the crossed-out relationship between Z to U in Figure 7. The condition is 
also appealing conceptually since if the instrument were correlated with the residuals in the 
original equation, it would suffer from the same problem as the original OLS estimate. 
However, this condition is difficult to be confirmed because we cannot observe εkt. The third 
condition is the instrument (z) only affects the outcome through its effect on the treatment. 
This means that a good IV should to be highly correlated with a regressor but uncorrelated 
with εk in the equation (13). It is represented by the crossed-out line from Z to Y and Z to D to 
Y in Figure 7.  
In summary, even though the fixed effect and IV approaches were used in the 
reviewed literature, there are other approaches including DiD and PSM approaches that 
might be possible to apply in the study. The reason why other approaches are not so 
popular among researchers could be the reasonability of holding the required assumptions 
of each approach. The assumption needed for DiD estimator is that the time trend of the 
treatment group and comparison group is the same. PSM can only be based on the 
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observed characteristics of patients. At the same time, the reasons why the fixed effect 
accompanied by IV methods are used more often are that the hospital fixed model could 
control variations within hospital and the IV controls for variations across these differences. 
IV is the only approach for mitigating the effect of bias caused by endogeneity.  
 
3.5. Conclusion 
 The ultimate goal of this study is to estimate the causal effect of the Kasai 
procedure on patient outcomes. The fundamental problem of causal inference persists in 
the fact that the outcome cannot be observed for the counter factual scenario for the same 
individual, and therefore, one must observe the average treatment effect of the entire 
sample. Experimental settings with successful randomization allow us to see the causal 
effect of the treatment on those who are assigned to the treatment through the evaluation 
parameter, average treatment effect on the treated. But since this study used observational 
data, the random allocation to the treatment cannot occur, and therefore, potential threats to 
causal inference such as selection bias and endogeneity exist to accurately estimate the 
treatment effect. 
Multivariate logit regression with rich sets of covariates, DiD, PSM, FE, and IV were 
reviewed for potentially mitigating bases. The problem with observational data is that there 
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are an infinite number of unobserved variables that could make the observed relationship 
endogenous. There are certain assumptions underlining in each approach. The core 
assumption associated with the DiD approach is that the time trend of the treatment group 
and comparison group is the same. For the PSM, there is a conditional independence 
assumption that that treatment status is random, conditional on some set of observed 
covariates. The FE approach assumes that the unobserved hospital characteristics, which 
do not change over time and do not interact with variables that do change over time. 
However, these methods only control for measured confounders and do not control for 
unmeasured characteristics. The IV method is therefore useful in conjunction with these 
other methods, because it has the potential to control for unmeasured characteristics. The 
core assumptions for the IV method are that the instrument must be related to the potentially 
endogenous question predictor, the instrument is independent of unmeasured confounders, 






None of previous literature in BA has addressed the problem of endogeneity when 
aiming to assess the effect of the timing of the Kasai procedure on patient outcomes. 
Moreover, only three studies based on the population-based datasets tried to control for the 
confounding variables (Lien et al., 2011; Chardot et al.,1999; Chardot et al., 2013). Their 
results suggested that in addition to the timing of the Kasai procedure, the anatomic pattern 
of BA, existence of associated anomalies, prophylactic antibiotics, and hospitals with high 
caseload independently associated with patient outcomes.  
Drawing from research literature in the fields of economics and education, four 
approaches were identified in order to correct for confounding in quasi-experimental 
research designs. The four approaches identified for use in this study were the DiD, PSM, 
FE, and IV methods.  
 
4.2. Data Description and Sample Selection 
This study used the data drawn from the Japan Biliary Atresia Registry (JBAR). In 
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1989, the Japan Biliary Atresia Society launched a nationwide registry to investigate all 
aspects of BA. A total of 2,743 patients (1,743 girls, and 1,000 boys) have been registered 
since then. The JBAR dataset includeed BA patients who were diagnosed as BA from 1989 
to 2012. The JBAR was based on the observational data gained through initial and follow-up 
questionnaires.  
The variables in JBAR included the sociodemographic background of patients, 
clinical and hospital characteristics. While the JBAR contained a lot of variables that have 
not been investigated previously, this study utilized a sub-set of these because some of 
them were still under the data cleaning process.  
The JBAR had a high rate of a national BA population coverage. While it is 
impossible to know the exact number of all BA patients due to the mortality rate associated 
with the disease, an estimate of the number of BA patients living in Japan is provided below 
in Table 8. According to the calculation, for an incidence of 1 in 9640 (Nio et al., 2003), the 
estimated total number of BA patients in Japan from 1989 to 2012 would be 2864. Therefore, 
the total number of patients captured in the JBAR from 1989 to 2012 was 2743, suggesting 
that the population coverage of JBAR was high (96%). This indicated that selection bias due 
to not representing the target population was not likely a major source of bias in this study. 
The use of a national population registry allowed for minimization of selection bias, and 
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could facilitate greater generalizability of the study findings to the target population. 
The inclusion criteria for this study stipulated that the subjects were born between 
1989 and 2012 and underwent a Kasai procedure. Also I only included patients in whom I 
could observe the primary predictor and outcome. However, the outcome was not observed 
or unknown for 122 patients identified in the registry, and therefore these patients were 
excluded from the study. There were also additional 16 subjects who did not receive a Kasai 
procedure, and were therefore also excluded. 
The primary predictor variable used in this study was the age at Kasai procedure 
and the outcome was 1-year survival of native liver, and data for both and were present in a 
total of 2605 subjects. The timing of Kasai procedure was broken into categories starting the 
less than 30 days, and incremented by 15 day periods. The number of subjects receiving 
the Kasai procedure less than 30 days was 158, 525 for less than 45 days, 1147 for less 
than 60 days, 1,780 for less than 75 days, 2175 for less than 90 days, 2,356 for less than 
105 days and 2,449 for less than 120 days. 
Other variables included sociodemographics including gender, birth order, birth weight, 
gestational age, parental age, clinical characteristics including type of obstruction, 
associated anomalies, and type of choleretic agents, and hospital characteristics including a 
hospital with a high caseload. Types of obstruction were defined according to the Japanese 
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Society of Pediatric Surgeons classification22. Associated anomalies were defined as any 
indication of situs inversus, asplenia, polysplenia, accessory spleen, and preduodenal portal 
vein23. Type of choleretic agents include dehydrocholic, ursodeoxycholic acid, secretin, 
steroid, PGE1, taurine, PG-F2α, and PG-E2. Hospitals with high case load was defined as 
hospitals which had the mean caseload (59) +1SD (31) cases.  
 
4.3. Estimation Strategy 
The assumptions in the empirical analyses can be based on two perspectives: the 
first that there were no unmeasured characteristics in the model, and the second was that 
instead, that there were some unmeasured characteristics left out from the model.  
Existing literature (Lien et al., 2011; Chardot et al., 2013) supported the idea that, a 
younger age at the time of the Kasai procedure consistently has been found to be 
associated with better outcomes. These empirical studies supported that early diagnosis 
had an impact on later outcomes as a pathway through the early intervention of the Kasai 
procedure. Recall the following shows the basic empirical model to estimate the effect of the 
early Kasai intervention on the outcome.   
log(p/(1-p))SNL kt  = α0 +β1Kkt + β2Xkt +αkt+εkt --- (7) 
                                                   
22 See Figure 2 for the description of types of obstruction 
23 See Table 1 for the description of associated anomalies and choleretic agents  
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where SNL kt is a probability of survival of native liver at t (5-, 10-, 15-, and 20-year) 
with k individual. Although including the long-term outcomes in the analysis was my ultimate 
interest, the data in hand only allowed examining the effect on the short-term outcome, 
1-year native liver survival without jaundice. A native liver survival without jaundice has been 
considered as good prognosis, and its association with better long-term prognosis has been 
suggested in prior research (Lien et al., 2011). The independent variable in this analysis was 
the timing of Kasai procedure. Kkt is the timing of the Kasai procedure. Xkt is a vector of other 
inputs that influence survival of native liver. αkt indicates the child innate healthiness that 
would affect the progress and severity of the disease. εkt is an error term that captures 
unmeasured variables. 
  According to the previous studies, anatomic pattern (Nio et al., 2006), existence of 
malformation (Shneider et al., 2006; Dillon et al., 1994; Davenport, 2006; Schwarz et al., 
2013), and expertise of the surgeon and care center had strong associations with the 
outcome (Davenport et al., 2011; Chardot et al., 1999). These characteristics should be 
reflected in Xkt, 
 
4.3.1. Bivariate Analysis 
I conducted a bivariate analysis to investigate the direct relationship between the 
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outcome and the timing of Kasai procedures and other covariates. This process was 
important for two reasons: First of all, the most of previous literature only looked at bivariate 
relationship between the timing of the Kasai procedure and outcome; therefore by 
conducting the bivariate analysis, the result would be comparable to the previous studies. 
The results were also compared to the results from the multivariate analysis and examined 
the difference among them.  
 
4.3.2. Multivariate Analysis 
In the multivariate analysis including  logit/probit regressions, it was assumed 
there was no left-out or confounding variable that may generate the biased estimates 
associated with the effect of the timing of Kasai procedure on patient outcomes.  
The covariates used in the multivariate analysis included sociodemographic 
characteristics (e.g. gender, birth order, birth weight, gestational age, parental age), clinical 
characteristics (e.g. type of obstruction, associated anomalies, and type of choleretic 
agents), and hospital characteristics  (e.g. hospital caseload).  
Since the dependent variable in the analysis (1-year native liver survival without 
jaundice) was dichotomous, the relationship between the dependent variable and 
independent variables was non-linear because the probabilities were bound between 0 and 
1. Even though binary outcomes are a result of a latent variable which is continuous and 
88 
  
normal, the results from probit regression can be difficult to interpret. Therefore, in this study, 
the results of the two regression models, logit and probit regressions were compared.  
 The appropriate selection of potential confounders and inclusion into the model 
has been widely discussed in the epidemiologic literature (Budtz–Jørgensen et al., 2007; 
Maldonado and Greenland, 1993). A decision on the best set of variables in the model might 
be based on the clinical or statistical significance. In this study, first I examined that whether 
statistical and clinical significance of covariates were previously suggested or not and 
examined that the variables were statistically significant in the bivariate analysis. The study 
further examined the inclusion of the variable leads to a 10% change in the main effect in 
the logit regression. The selection rule was that if the variable was suggested to have a 
previous indication for its significance, statistical significance in the bivariate analysis, or 
leaded to a 10% change in the main effect when it was added to the model, then it was 
included. 
A ROC was also used as a measure of model fit. The points on the line indicate the 
probability of correctly predicting the outcome. It covers all possible thresholds (cut-off 
points) and the closer the ROC plot is to the upper left corner, the higher the overall 
prediction (Zweig and Campbell, 1993).  
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  Since confounding does not solely depend on statistical significance or the 10% 
rule26, a cut-point for defining confounding has not been fully established. Budtz–Jørgensen 
et al., 2007) provides a good example in their statistical analysis section describing how they 
analyzed raw test scores adjusted for previously suggested confounders. Their covariates 
were included in the full model if the p-value was less than 0.20 or if their inclusion resulted 
in a change of 10% or more in the estimate of the main effect of the outcome. Following the 
suggested rules, this study compared the predictability of the outcome in the model with full 
covariates and also the model with selected covariates.  
 
4.3.3. Fixed Effect 
The reason for using FE was to address the fact that the characteristics of hospital 
would affect both the timing of the Kasai procedure and the outcome.  
Recall the equation (7), one can estimate the parameter τ from the regression:  
log(p/(1-p))SNL kt  = α0 +β1Kkt + β2Xkt +τZkt + γk t εkt --- (14) 
where Z for two (or more) “paired” observations with the same hospital.  
                                                   
26 Variables that were not significantly associated with disease severity but that changed the odds ratio for severity 




The rationale behind FE is that the timing of the Kasai procedure varied within 
hospitals but any hospital characteristics affecting the timing of the Kasai procedure and 
outcome were unlikely to vary significantly within each hospital. In this setting, correlation 
between the timing of Kasai procedure and the outcome should not be detected within a 
single hospital. My hypothesis, and rationale for using FE regression was that if the variable 
for hospital characteristics in the multivariate logit regression (defined as the hospital with 
higher case load [more than 1SD of the mean caseloads of all hospitals]) accounted for the 
variations in hospital characteristics, then the results between the multivariate logit 
regression and FE would be the same.  
 
4.3.4. Instrumental Variable  
The study performed the multivariate regression with rich covariates and FE to 
address the scenario whereby no confounding was unobserved. As discussed in detail in 
section 3.2.5., there is the problem of latent endogeneity when estimating the effect of the 
Kasai procedure on outcomes. Besides the fact that much is unknown about the cause of 
BA, there would be potentially observable characteristics that are not included in JBAR data. 
Such variables could be characteristics of medical institutions including expertise and 
motivation of staff, parents’ characteristics relating to the management of a process of 
screening and post-operation periods, (e.g. adherence to medication), and hospital and 
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local government characteristics relating to investments in child health services. In other 
words, there would be a non-zero correlation between the question predictor and residuals 
in the population. In any of these cases, estimates of the timing of the Kasai procedure using 
multivariate logit regression or with FE will be biased. In order to account for such 
endogeneity bias, one strategy is to use IV estimation.  
Two possible instrumental variables were considered for the analysis: 1) whether 
or not patients received any kind of screening prior to the Kasai procedure and 2) length of 
stay at last hospital admission prior to having the Kasai procedure. For the first instrumental 
variable in the dataset, there is a variable describing whether or not patients received any 
kind of screening prior to being referred to the hospital for detail examinations.  
Two different functional forms were used in this analysis. As it is stated in Angrist & 
Pischke's book, Mostly Harmless Econometrics (Angrist and Pischke, 2009), combining IV 
with either probit or logit is not an optimal approach because the econometrics are more 
complicated and prone to errors; therefore, I useed both OLS and probit regressions to 







In the multivariate analysis including multivariate logit and probit models, it is 
assumed there are no unobservable characteristics that change over time and can affect 
patient outcomes in the ways explained that are associated with selection and endogeneity 
biases in the estimation strategies used in the analyses. Potential problems associated with 
child’s innate healthiness and hospital characteristics are ruled out in the analyses by 
controlling for birth weight and the indication of hospital with high caseload in the model. The 
validity of controlling the hospital effect with the covariate indication the hospital with higher 
caseload is compared with the hospital FE. If there is an endogeneity issue, then the IV 
should be taken.  
The reviewed assumptions are needed in order to argue the unbiasedness of the 
coefficients estimated under the different models; however, this does not mean the 
assumptions are realistic and convincing. By comparing the results from the different 
statistical models, I will examine which model could give us the most persuasive answer to 






5.1. Descriptive Statistics 
The descriptive statistics were summarized in Table 8. Table 8 suggests that there 
were 956 boys, 37% of patients, and 1643 girls, 63% of patients, the median birth order was 
2 with the interquartile ranging from 1 to 2, the mean birth weight was 2916.9g with ±449SD, 
the mean gestational age was 38.7 weeks with ±1.7 SD, the mean age of father was 31.9 
years ±5.8 SD and the mean age of mother was 29.5 years old with ±4.6 SD. For the clinical 
characteristics, the mean age at the Kasai procedure was 67.6 days with ± 29 SD, 4% of 
patients was type I, 8% was type I-cyst, 2% was type II and 85% was type III, 5% of patients 
had associated anomalies, 42% of patients had cholangitis, usodeoxycholic acid (87%) and 
steroid 88% were frequently used. 1-year survival of native liver was achieved by 1551 
patients (60%).  
 
5.2. Bivariate Analysis 
Table 11 shows the results of the bivariate analysis of 1-year native liver survival 
without jaundice by the timing of the Kasai procedure. The results show that there are 
94 
  
statistically significant differences for the Kasai procedure at less than 30 days (p=<0.001) 
and 45 to 60 days (p=0.001) with a larger percentage of patients in the favorable outcome 
group, while the Kasai procedure at 76 to 90 days (p=0.004), 106 to 120 days (p=0.002) and 
over 121 (p<0.001) had a larger percentage of patients in the poorer outcome group.  
Figure 8 shows the 1-year native liver survival without jaundice and the age at the 
Kasai procedure. There is a descending trend in the relationship between 1-year native liver 
survival without jaundice and the age at the Kasai procedure; however, the relationship 
does not appear linear. The slope within the first 30 days appears steeper than the slope 
thereafter and the slope between 31 days to 55 days appears to almost flatten.   
Figure 9 shows the relationship between the 1-year native liver survival without 
jaundice and the Kasai procedure more specifically across by two groups based on the 
timing of the Kasai procedure at less than 60 days and 60-120 days. The relationships are 
consistent with the results of the bivariate analysis showing almost no slope for the Kasai 
procedure done at age 31 to 45 days and those done between 61 to 75 days. The different 
timing of the Kasai procedure seemed to have different magnitudes of the effect on 1-year 
native liver survival without jaundice.  
Figure 10 shows a slightly concave relationship between 1-year survival of native 
liver and the Kasai procedure performed between 31 to 70 days of age. This simple image 
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suggests that age of the Kasai procedure between 30 and 50 days has a slightly positive 
relation with the outcome.  
Table 12 shows the bivariate analysis evaluating sociodemographic characteristics 
and clinical and hospital characteristics with relation to 1-year native liver survival without 
jaundice. Survival with native liver without jaundice did not appear to be associated with 
gender, birth order, birth weight, gestational age, and age of parents. The results were in 
accordance with the previous studies showing no association between the disorder and 
sociodemographics (Superina et al., 2011; The et al., 2007).  
The results showed statistically significant differences in types of obstruction, the 
use of dehydrocholic (p<0.001), and ursodeoxycholic acid (p<0.001), and hospitals with 
higher caseload (p=0.01) which had larger proportions among the native liver survival group. 
In contrast, associated anomalies and cholangitis had larger proportions among the 
non-native liver survival group.  
  
5.3. Multivariate Analysis 
Figure 11 shows the histogram of the timing of the Kasai procedure. It has two 
peaks existing at around 60 days and around 80 days. The mean age of the Kasai 
procedure was 67.6. Therefore, in the basic logit regression, the reference group was 
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defined as patients receiving the Kasai procedure between ages 61 to 75 days.  
 The results of logit/probit regressions without adjustment for covariates are 
presented in Table 13 in order to assure the comparability between two regressions with 
different link functions. Comparison to the reference group, receiving the Kasai procedure at 
less than 30 days of age increased the log odds of 1-year native liver survival without 
jaundice by 0.553 and it was statistically significant at (p<0.05)  By taking the exponential 
of the log-odds ratio, I calculated an odds ratio of 1.7. This suggests that patients who 
received the Kasai procedure less than 30 days of age were 1.7 times more likely to achieve 
1-year native liver survival without jaundice. Interestingly, age 31 to 45 and 46 to 60 days at 
the Kasai procedure were not statistically significant, though their coefficients suggested a 
positive relationship with the outcome. These results were consistent with observations 
exhibited in Figure 9 that showed age of the Kasai procedure between roughly around 30 
and 55 days having no relationship with the 1-year native liver survival without jaundice. 
Their magnitudes are relatively small (31-45 days: 0.0153; 46-60 days: 0.127).  
Unlike the results for the earlier timing of the Kasai procedure, the coefficients of 
the four categories corresponding to later the Kasai procedure showed negative 
associations with the outcome. Both the magnitudes and statistical significance became 
larger with later timing of the Kasai procedure except for the group having the Kasai 
97 
  
procedure between 91 to 105 days. Those who underwent the Kasai procedure after 120 
days of age showed decreased log odds for 1-year native liver survival without jaundice by 
1.3. This equated to them being 0.27 times as likely to achieve 1-year native liver survival 
without jaundice.  
For the probit regression (also shown in Table 13), the Kasai procedure at less 
than 30 days of age in comparison to the Kasai procedure at 61 to 75 days increased the 
z-score of 1-year native liver survival without jaundice by 0.335 and was statistically 
significant at the 5% level. The results of the probit regression were similar to the results of 
the logit regression with regards to the magnitude of association and statistical significance. 
In order to assure their comparability, the ratios of their coefficients were calculated and are 
shown in the last column of Table 13. The ratios of the coefficients between logit and probit 
appeared constant across the different categories; therefore, their results were comparable 
in terms of signs and magnitudes of the coefficients.  
 Table 14 described the covariates selection approach. Among the 
sociodemographic variables included in the analysis, only birth weight was found to meet 
the threshold criteria of p-value was less than 0.20., The types of obstruction, associated 
anomalies, cholangitis, and hospital caseload were included in the final model because their 
associations with the outcome are previously suggested and also statistically significant in 
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the bivariate analysis. Among the use of choleretic agent, both dehydrocholic and 
ursodeoxycholic acid were  included because of prior suggestion and statistical 
significance in the bivariate analysis. Steroid was included because results from a previous 
RCT study (Bezerra et al., 2014) suggested its negative impact on the short-term prognosis 
of patients.   
The results of the multivariate logit regressions with full covariates, selected 
covariates and with hospital fixed effect are shown in Table 15. The reference group was 
patients whose age at the Kasai procedure was between 61 to 75 days and who had an 
anatomic pattern of type III. As opposed to what was observed in the basic logit regression 
without any covariates, the Kasai procedure at less than 30 days of age was no longer 
statistically significant. However, the other earlier categories of the timing of the Kasai 
procedure tuned into not statistically significant as well, although their direction of effect 
suggested positive associations with 1-year native liver survival without jaundice.  
In contrast, the coefficients of all of four later categories of the timing of the Kasai 
procedure showed negative impacts on the outcome. Both the magnitudes and statistical 
significance become larger with later timing of the Kasai procedure except for the group 
having the Kasai procedure at 91 to 105 days. For those who underwent the Kasai 
procedure after 120 days of age, there was a decrease in log odds by 1.3, suggesting an 
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association with 1-year native liver survival without jaundice. This can be interpreted as 
them being 0.27 times as likely to achieve 1-year native liver survival without jaundice 
holding all other variables constant.  
 Type I, type I with cyst and type II obstructions were all independently associated 
with increased probability of achieving 1-year native liver survival without jaundice as 
compared to the type III group. Of all patients, 4% (n=101) were type I, 8% (n=212) were 
type I with cyst, 2% (n=54) were type II, and 86% (n=2065) were type III. When compared to 
those who had type III obstruction, patients with type I obstruction had a log odds of 0.757 
for 1-year native liver survival without jaundice. This represented a 2.13 times greater 
likelihood of achieving 1-year native liver survival without jaundice for type I obstruction 
patients compared to patients with type III obstruction independent of other covariates in the 
model. For type I with cyst, the log odds ratio was 1.487 and represented a 4.4 times greater 
likelihood of achieving the favorable outcome. Type II patients showed a log odds ratio of 
0.76 with a magnitude of effect that was similar to type I, but with less statistical significance. 
These results confirmed that patients having the type III anatomic pattern had a lower 
probability of achieving 1-year survival of native liver.  
 Associated anomalies were negatively associated with the outcome and showed 
borderline statistical significant at the 5% level, and cholangitis showed a negative 
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relationship with the outcome after adjustment for covariates. The log odds ratio of 
cholangitis was -0.254 which was equivalent to odds ratio of 0.78.  
 Among the variables related to choleretic agents, the dehydrocholic and 
ursodeoxycholic acid showed positive associations with the outcome after adjustment for 
potential confounding. Particularly, the ursodeoxycholic acid showed a log odds ratio of 
0.587, which indicated a 1.7 times greater likelihood of achieving 1-year survival of native 
liver compared to those who were not treated with this agent. In contrast, steroid use was 
independently associated with a decreased probability of achieving the favorable outcome 
showing a log odds of 0.413. Hospital caseload showed a suggestive association with a log 
odds ratio of 0.219 which is equivalent to an odds ratio of 1.24.  
 The two models in the analysis, one with full covariates and the other with selected 
covariates showed very similar results despite difference in sample size availability. A ROC 
was produced (Figures 12 and 13), and used as a measure of model fit. The areas under 
the ROC were similar for the two models; 0.659 for the full model and 0.656 for the selected 
covariates model. This suggested that the two models performed similarly with respect to 





5.4. Stratified Multivariate Analysis 
 Figure 14 showed the relationship between the 1-year native liver survival without 
jaundice and the timing of the Kasai procedure by the types of obstruction. There were 91 
subjects in the type I group, 199 in type I with cyst, 47 in type II, and 2,065 in type III. 
Surprisingly, for the type I and type II groups, there were no patients who had a Kasai 
procedure after 200 days of age. The four groups showed very different trends in the 
relationship between the timing of the Kasai procedure and the outcome.  
Table 16 showed the predictors of 1-year native liver survival without jaundice 
stratified by the types of obstruction adjusted for sociodemographics, clinical and hospital 
characteristics. The reference group was patients whose age at the Kasai procedure was 
between 61 and 75 days. The coefficients associated with the early timing of the Kasai 
procedure compared to the reference group were not statistically significant, with the 
exception of the type III patients who had a Kasai procedure at less than 30 days when 
evaluated at the 10% significance level. This finding indicates that the Kasai procedure at 
less than 30 days of age in comparison to the Kasai procedure from 61 to 75 days increased 
the log odds of 1-year native liver survival without jaundice by 0.553 and it was statistically 
significant at the 5% level. For type III patients, the result showed a log odds ratio of 0.43 
with borderline statistical significance for patients who had the Kasai procedure at less than 
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30 days, which was similar to the result of the multivariate logit regression (odds ratio of 0.32. 
z=1.49). However, in the model stratified by types of obstruction and controlling for 
covariates, not only were the estimates no longer statistically significant for timing of the 
Kasai procedure less than 30 days of age.  
Generally, the coefficients of most of the four later categories of the timing of  
Kasai procedure showed a negative impact on the outcome regardless of their type of 
obstruction. For the type I group, timing of the Kasai procedure was not independently 
associated with the outcome after controlling for potential confounding. For the type I with 
cyst group, only the timing of the Kasai procedure over 121 days showed a decreased 
probability of achieving 1-year native liver survival without jaundice. For the type II group, 
though affected by small sample size, the timing of the Kasai procedure from 76 to 90 days 
and over 121 days showed a negative association with the outcome. Both the magnitude 
and statistical significance increased with later timing of the Kasai procedure for the group 
receiving the Kasai procedure at 91 to 105 days. In type II group, receiving the Kasai 
procedure after 121 days of age decreased the log odds of 1-year native liver survival 
without jaundice by 1.3. This means that they were 0.27 times as likely to achieve 1-year 
native liver survival without jaundice independent of other covariates in the model.  
For the type III group, both the magnitude and statistical significance increased 
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with later timing of the Kasai procedure, except for the group having the Kasai procedure at 
91 to 105 days. Receiving the Kasai procedure at 106 to 121 days of age decreased the log 
odds of 1-year native liver survival without jaundice by 0.83. This means that these patients 
were 0.43 times as likely to achieve 1-year native liver survival without jaundice holding 
other covariates constant. The Kasai procedure after 121 days of age also decreased the 
log odds of 1-year native liver survival without jaundice by 1.17, meaning that these patients 
were 0.3 times as likely to achieve 1-year native liver survival without jaundice holding other 
covariates constant. 
The birth weight and associated anomalies were not associated with the outcome. 
For type I patients, patients with cholangitis showed to be 0.14 times as likely to achieve 
1-year native liver survival without jaundice after adjustment for potential confounders. 
Among patients with the type I with cyst, results for cholangitis suggests to be 0.22 times as 
likely to achieve 1-year survival of native liver after adjustment. The result for patients with 
type III was also in the same direction showing them to be 0.79 times as likely to achieve 
1-year native liver survival without jaundice. These results for the effect of cholangitis across 
the subgroups suggest that patients who are type I may be more likely to be affected by the 
negative impact of cholangitis on 1-year native liver survival without jaundice followed by 
type I cyst and type III. The relationship in type II patients could not be evaluated due to 
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limitations in sample size.  
The results on the use of choleretic agent suggest that dehydrocholic was not 
associated with the outcome. The ursodeoxycholic acid was statistically significant in the 
type I, type I with cyst, and type III groups with the log odds ratios of 4.27, 1.61, and 0.54, 
respectively. Steroid treatment was negatively associated with the outcome in all four 
groups but statistically significant only in the type I group with the log odds ratio of -4.86. The 
statistically significant effect of the higher hospital case load was observed only in the type 
III group with a log odds ratio of 0.25. 
 
5.4. Fixed Effect 
In regard to the signs and magnitudes of the effect of each variable, the results 
obtained for the FE were very similar to the results on the multivariate logit regression with 
selected covariates except for the significance of the timing of the Kasai procedure less than 
30 days. In the FE model, it turned out to be statistically significant at 5% level. It showed 
that increased log odds by 0.458 and was associated with 1-year native liver survival without 
jaundice. This can be interpreted as them being 1.6 times as likely to achieve 1-year native 
liver survival without jaundice holding all other variables constant. 
In contrast, the coefficients of all of four later categories of the timing of the Kasai 
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procedure showed negative impacts on the outcome. Both the magnitudes and statistical 
significance became larger with later timing of the Kasai procedure except for the group 
having the Kasai procedure at 91 to 105 days.  
 
5.5. Instrumental Variable  
Two possible instrumental variables were considered for the analysis: 1) whether 
or not patients received any kind of screening prior to the Kasai procedure and 2) length of 
stay at last hospital admission prior to having the Kasai procedure. For the first instrumental 
variable, there was a variable describing whether or not patients received any kind of 
screening prior to being referred to the hospital for detail examinations. 
 A total of 23 patients received some form of screening prior to a Kasai procedure 
showed in Table 10, representing 1% of the total subgroup patients. The other screening 
methods included measurement of conjugated bile acids in dried blood spots using tandem 
mass spectrometry, serum conjugated bilirubin after birth, measuring urinary sulfated bile 
acid, and measurement of fecal conjugated bilirubin by near-infrared reflectance 
spectroscopy and each of them was performed in the selected hospitals and was offered 
partly as clinical researches.  
The limitation of using the screening variable as the instrument was the fact that 
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the number of observation was too small; therefore, it is not sufficient to explain any 
variations in the timing of the Kasai procedure. Since 2012, the national stool color card has 
been implemented, so in few years the larger numbers of patients who have screening are 
expected and makes IV analysis possible with this instrument. 
The second instrument was the length of stay at last hospital admission prior to 
having the Kasai procedure. It is used as a proxy for the accessibility to the nearest hospital 
with high-level hospital which means that the hospital with a specialized surgeon and facility. 
In the IV analysis, I dichotomized the timing of the Kasai procedure less or more 
than 30 days, 45 days, 60days, 75 days, 90 days, 105 days and 120 days for simplicity of 
interpretation and discussion.  
The results of 2SLS are summarized in Table 18. The results on OLS and probit 
regression without any adjustments are shown in the first two columns, adjusted for 
sociodemographics, hospital and clinical characteristics are also shown in the third and 
fourth columns of Table 18 as baseline references. The results in both OLS and probit 
regression suggested that the timing of the Kasai procedure was independently associated 
with the 1-year native liver survival without jaundice while any of the timings of the Kasai 
procedure in 2SLS do not significantly explain the probability of 1-year native liver survival 
without jaundice. The signs and t-value or z-score were consistent in two models which 
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confirmed that the choice of the model did not affect the results in the analysis.  
5.6. Discussion 
Recalling log(p/(1-p))SNL kt  = α0 +β1Kkt + β2Xkt +αkt+εkt --- (7), in this empirical 
analysis, the outcome was measured as 1-year native liver survival without jaundice. The 
timing of the Kasai procedure was divided into 8 groups ranging from the group having the 
Kasai procedure at less than 30 days incremented by 15 days up to over 121 days because 
some of the previous studies suggested that earlier intervention was associated with better 
prognosis (Schreiber et al., 2007; Chardot et al 1999, 2013). While the traditional approach 
for defining the timing of the Kasai procedure was to divide it into two groups with a cut-off 
point at 60 days of age, the categorization into 8 groups used in this research allowed us to 
see not only the effect of the timing of the Kasai procedure before 60 days, but also after 90 
days, which has previously been reported to be associated with worse prognosis (Chardot et 
al., 1999, 2001).   
The full covariates included sociodemographics and clinical and hospital 
characteristics. The incidence of associated anomalies seemed low in this study, and this 
was likely because that this study did not include cardiac anomalies. Previous studies have 
suggested the incidence as 10 to 15 percent of infants with BA (Schreiber et al., 2007) and 
have shown to be related to poorer outcomes. The incidence of cholangitis in this study 
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seems somewhat low (42%) compared to other previous studies that ranged from 40% to 
90%, with the majority of patients experiencing at least one episode prior to two years of age 
(Luo and Zheng, 2008; Sokol et al., 2007). 
As previous literature (Muise et al., 2006; Nio and Muraji, 2013; Nio et al., 2006; 
Nio et al., 2010; Stringer et al., 2007; Superina et al., 2011) and the figures from this study 
also suggested, the types of obstruction have a substantial impact on patient outcomes. The 
results from the multivariate analysis adjusted by types of obstruction showed that receiving 
the Kasai procedure within less than 30 days of birth had a suggestive impact (z=1.79) only 
for the type III patients. According to this result, there was a possibility that a Kasai 
procedure at less than 30 days might improve the short-term outcome for patients who have 
a type III obstruction. This difference might be explained by the fact that types of obstruction 
may be associated with the baseline severity and progress of the disease as it was 
previously reported that Type I BA (atresia of the common bile duct), or so called correctable 
atresia, showed a better prognosis when comparing to type II and III (Superina et al., 2011).  
The small sample size (particularly for type II [n=49]) might explain the lack of 
statistical power, and therefore, the lack of significance of the coefficients. Also the 
confidence intervals were rather large for type I, type I with cyst, and type II. However, as 
observed both in Table 16 and Figure 14, the signs, magnitudes, and general trends 
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between the timing of Kasai and 1-year native liver survival were different among four 
different types of obstruction. For type I, type I with cyst and type II, although not statistically 
significant, the earlier timing (less than 45 days) of Kasai procedure had a negative impact 
on achieving 1-year native liver survival in general, and this was associated with a 
contraction of the effect for type III. These findings were also depicted from Figure 14, 
suggesting that there were almost flat relationships between the earlier timing of Kasai 
procedure and the outcomes for type I and type I with cyst. From these observations, for 
type I and type I with cyst, there seemed to be a different effect of the timing of the Kasai 
procedure on the outcome, with the opposite directional impact. For type II, a larger sample 
size would be required to reach a meaningful conclusion.  
The hypothesis behind the application of FE in the study was that the timing of the 
Kasai procedure varied within hospitals but any hospital characteristics affecting the timing 
of the Kasai procedure and outcome did not vary within each hospital. In this setting, within 
hospital correlation of the timing of the Kasai procedure and the outcome should not be 
detected. My hypothesis in FE regression was that if the variable for hospital characteristics 
in the multivariate logit regression (defined as hospitals with higher case load compared to 
the mean caseloads out of all hospitals) accounted for the variations in hospital 




However, the results from the FE suggested a slightly different effect for the timing 
of a Kasai procedure at less than 30 days. In the FE model, it turned out to be statistically 
significant (p<0.05). FE results showed an increased log odds of 0.458 and were associated 
with 1-year native liver survival without jaundice, suggesting that receiving the Kasai 
procedure at less than 30 days after birth was 1.6 times as likely to achieve this outcome 
independent of other covariates in the model. Therefore, there still might be unmeasured 
hospital characteristics that would affect both the timing of the Kasai procedure and the 
outcome.  
The limitation of FE is that it can only exclude any impact associated with 
time-invariant within-hospital characteristics that may affect the dependent variable. The FE 
analysis did not account for variations in innate child healthiness or random shocks to timing 
of the Kasai procedure among patients within the same hospital. 
For the IV analysis, I used a shorter length of stay at the last hospital admission 
where patients had their Kasai procedure as a proxy for the accessibility to the nearest 
high-level hospital. My hypothesis was that the longer the length of hospital stays prior to the 
Kasai procedure, the higher the probability that patients may live farther from a high-level 
hospital. The rationale was that if patients lived close to a high-level hospital then the 
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screening could be done on an outpatient basis, whereas if patients lived far from the 
hospital, they would prefer to be examined and screened on an inpatient basis.  
The first stage results summarized in Table 17 suggested that in the first four groups, 
having the Kasai procedure less than 30 days, 45 days, 60 days, and 75 days, the 
coefficients of length of stay at last hospital admission prior to receiving the Kasai procedure 
were statistically significant. These findings suggest that the IV was related to the timing of 
the Kasai procedure while holding other predictors constant.  
To see the strength of the instrument, I performed the diagnostic test. The most 
common diagnostic test of the first-stage is the F‐statistic on the excluded instrument. A 
rule of thumb is that the F should be above 10 (Stock, Wright and Yogo, 2002). F-statistics 
above 10 were observed in KP less than 30 days, 45 days, 60 days, and 75 days (10.7, 42.6, 
74.4, 15.9 accordingly) but not for the rest of group. These results suggested that the first 
four IVs were strong, but not for the later timing of the Kasai procedure. The IV used for the 
timing of the Kasai procedure after 90 days were weak; therefore, the IV estimates may had 
have high variance, and their partial first-stage F statistics were less than 10, therefore, it 
was better to use inference methods other than 2SLS. 
Table 19 and 20 show the full results on adjusted OLS and probit regression and 
Table 21 and 22 show the results on 2SLS and probit with IV. While in OLS and probit 
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regressions, type I, type I with cyst, and type II anatomic patterns showed a positive 
association with the outcome, as did use of ursodeoxycholic acid and the hospital with 
higher case load. However, type III anatomic pattern, cholangitis and use of steroid therapy 
showed a negative impact on the outcome. In the results of the 2SLS and probit with IV 
models, these variables stayed as significant as they were in the OLS and probit regression 
while the timing of the Kasai procedure was found to be statistically nonsignificant. These 
findings suggested that types of obstruction, cholangitis, the use of choleretic agents, and 
the hospital caseload were mediating variables that interacted with the timing of the Kasai 
procedure in determining 1-year survival of native liver with jaundice. 
The difference in the significance of the effect of the timing of the Kasai procedure in 
OLS and 2SLS leading to wonder which models would be most accurate. Therefore, I 
performed the Wu-Hausman test for the 2SLS model; the null hypothesis was that there was 
no difference between the OLS and the 2SLS model. The hypothesis had assumed that 
there had not been an endogeneity problem. Moreover, if there was no endogeneity 
problem, both OLS and 2SLS would be consistent, but 2SLS was inefficient. Estimating the 
2SLS model showed that the test was not significant for the timing of the Kasai procedure 
(KP<30 p=0.65, KP<45 p=0.77, KP<60 p=0.83, KP<75 p=0.94, KP<90 p=0.69, KP<105 
p=0.68, KP<120 p=0.61). The Wu-Hausman tests were not statistically significant, thus 
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failing to reject the null hypothesis that the estimates of both the models were consistent. 
This suggested that the 2SLS model was not the preferred model and the timing of the 
Kasai procedure was not endogenous, and therefore, IV was not the preferred estimator. 
Also the results of the analyses using OLS and probit models were not radically different 









6.1. Summary of Findings 
 The goal of this study was to use different statistical models to assess the 
associations and to answer causal question on the effect of the timing of the Kasai 
procedure on patient outcomes. To date, none of the available literature on the timing of the 
Kasai procedure’s effect on BA patient outcomes has addressed the problem of 
endogeneity. Moreover, only three studies using population-based datasets tried to control 
for confounding (Lien et al., 2011; Chardot et al.,1999; Chardot et al., 2013). Their results 
suggested that in addition to the timing of the Kasai procedure, the anatomic pattern of BA, 
existence of associated anomalies, prophylactic antibiotics, and hospitals with high 
caseload had independent association with patient outcomes.  
I reviewed the literature in economics and education specifically to examine the 
effect of health status on education to learn the methodology and approaches used to 
mitigate potential biases. Four approaches that were reviewed include DiD, PSM, FE, and 
IV approach. Among the four approaches that were reviewed, multivariate logit/probit 
regression, hospital FE, and IV were selected for use in this study.  
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Figure 15 shows the multiple estimation results with 95% confidence interval 
combined. It displays four multivariate logit regression models including with no covariates 
(blue), with full covariates (red), with selected covariates (orange), and with hospital fixed 
effect (green) that examined the effect of Kasai procedure on 1-year native liver survival. It 
presents the four models by plotting parallel lines for each of them grouped by coefficients. 
As it is suggested in Figure 15, in terms of the magnitude of the coefficients, the types of 
obstruction have the largest impact on the outcome though the confidence intervals are 
rather large. Particularly, there was a difference in terms of the odds ratios between the blue 
dot and the rest of the dots for the timing of Kasai procedure less than 30 days. The blue dot 
is based on the bivariate analysis of 1-year native liver survival without jaundice by the 
timing of the Kasai procedure less than 30 days. There was a statistically significant 
difference for the Kasai procedure at less than 30 days (p=<0.001) with a larger percentage 
of patients in the favorable outcome group. However, when sociodemographic, clinical and 
hospital characteristics were controlled, the log odds ratio of achieving the 1-year native liver 
survival without jaundice for the Kasai procedure at less than 30 days of age decreased and 
became statistically non-significant in all but the model with the hospital fixed effect (green 
dot). This suggests that the effect of Kasai procedure at less than 30 days was more 
susceptible to other factors affecting the outcome such as the types of obstruction and 
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hospital characteristics.  
The results from this study differed from those of previous studies in that the findings 
showed that patients who underwent a Kasai procedure at ages 31 to 45 days and 46 to 60 
days did not have a statistically significant improvement in the outcome variable, though 
their coefficients did suggest a positive relationship with the outcome. These results were 
consistent with observations presented in Figure 8 that showed age of the Kasai procedure 
between 30 and 55 days having no relationship with native liver survival without jaundice 
and their magnitudes effect are relatively small (31-45 days: 0.0153; 46-60 days: 0.127) 
while holding everything else constant.  
While previous studies and also the bivariate analyses showed that there was a 
negative association between the timing of the Kasai procedure and patient outcomes, the 
analysis of the timing of the Kasai procedure indicated that as compared to the reference 
group defined as patients receiving the Kasai procedure between ages 61 to 75 days, the 
effect of earlier timing of the Kasai procedure that were at less than 30 days, 31-45 days, 
and 46-60 days, did not significantly explain 1-year native liver survival without jaundice 
after adjusting for covariates. The stratified logit regression by types of obstruction suggest 
that the timing of the Kasai procedure did not affect the outcome in the patients with type I 
and type I with cyst. Only in the type III group did the timing of the Kasai procedure at less 
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than 30 days showed a suggestive association to the increased probability of achieving 
1-year native liver survival. Later timing of the Kasai procedure was associated with 
decreased probability of achieving 1-year native liver survival except for the Kasai 
procedure at 91 to 105 days. 
 As previously suggested, the type I, type I with cyst and type II obstructions were 
all independently associated with increased probability of achieving 1-year native liver 
survival without jaundice as reference to the type III group. These results also confirmed that 
patients having the anatomic pattern of type III have a lower probability of achieving 1-year 
survival of native liver.  
 Cholangitis showed a negative relationship with the outcome after adjustment for 
covariates as suggested in the previous study. However, associated anomalies were not 
statistically significant in the multivariate logit regressions. This contradicts with the findings 
from previous studies but the difference may have been attributed to the definition and 
classification of the associated anomalies in each study.  
 Among the variables related to choleretic agents, only ursodeoxycholic acid 
showed the positive associations with the outcome after adjustment for potential 
confounding. In contrast, steroid therapy was independently associated with a decreased 
probability of achieving the favorable outcome.  
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 Hospital caseload showed an association with the outcome while adjusting for 
covariates. While it showed a positive relationship to the outcome in the type III group 
(log-odds ratio of 0.23, p<0.05), it did not show the association to the outcome in the groups 
with type I or type I with cyst. Further analysis with hospital FE was performed to see if there 
were any hospital characteristics rather than the caseload effect that would affect the timing 
of the Kasai procedure and the outcome. The result on FE suggested the slightly different 
effect of the timing of the Kasai procedure less than 30 days. This suggests that there still 
might be unmeasured hospital characteristics that would affect both the timing of the Kasai 
procedure and the outcome.  
By comparing the results on adjusted OLS and 2SLS, it revealed that types of 
obstruction, cholangitis, the use of choleretic agents, and the hospital caseload were 
mediating variables that interacted with the timing of the Kasai procedure in determining 
1-year survival of native liver with jaundice. 
 In sum, as opposed to the conventional wisdom, the results from the multivariate 
logit regression adjusted for covariates suggested that for patients with the obstruction types 
I and I with cyst, the timing of the Kasai procedure was not associated with 1-year native 
liver survival. As previously suggested, cholangitis and use of steroid showed negative 
associations to the outcome after adjustment for covariates. However, associated 
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anomalies were not statistically significant in the multivariate logit regressions which 
contradict with the previous findings but may be attributed by the definition and classification 
of the associated anomalies in each study. Ursodeoxycholic acid showed a positive 
association with the outcome. Hospital caseload also showed a positive association with the 
outcome while adjusting for covariates.   
 
6.2. Limitations: Dataset, Assumptions, and Interpretation 
 The limitation of this study is largely driven by the nature of this rare disease of 
which its etiology is not clear. There are both observed and unobserved processes that lead 
to determine the timing of the Kasai procedure, and these factors are correlated with 
survival with native liver, either directly or indirectly but very little is known about how these 
factors interrelate to each other. 
The dataset had its strength in terms of the largest subjects and was 
population-based. However, it also had some limitations. The outcome was not observed or 
was unknown for 122 patients, and was therefore excluded from the study.  
A total of 16 patients were also excluded from the study because they did not 
receive the Kasai procedure. While the outcomes for these 122 patients were unknown, 6 
out of 16 (37%) had died within one year. However, the clinical outcomes for the rest of 10 
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patients were not known since the JABR dataset did not contain information on liver 
transplantation for these patients. It is possible that they might have gone directly to the 
transplantation as a result of late diagnosis.  
Generalizability of the study results to the target population could be affected if the 
excluded patients were somehow different from those included in the study. In fact, for 
patients who underwent a Kasai procedure, the death rate was 6.8% within one year (117 
out of 2605). I suspect that those patients who did not undergo a Kasai procedure had a 
different background which therefore might have affected the outcome.   
 Random attrition and missing completely at random would not affect the point 
estimates, but would have an impact on the standard errors associated with them (i.e. they 
would become larger). However, if patients who have been dropped out of the sample had 
lower or higher probability of survival of native liver than patients who remained in the 
sample, then the coefficients associated with the determinants would be biased.  
The external validity of this study is expected to be high due to its population-based 
sample from a dataset that likely covers approximately 96% of BA patients in Japan. The 
Internal validity of this study is based on a set of assumptions made in the empirical 
analyses which were derived from two perspectives. The first perspective was that whether 
there were no unmeasured characteristics in the model was assumed. The multivariate 
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logit/probit regression and FE assumed that there were no unobservable characteristics that 
changed over time and can affect patient outcomes in the ways that were associated with 
selection and endogeneity biases. Potential problems associated with child’s innate 
healthiness and hospital characteristics were ruled out in the analyses by controlling for birth 
weight and the indication of hospital with high caseload in the model or by FE. In addition to 
these, the analyses assumed no heterogeneity in timing of the Kasai procedure effects.  
The second perspective was that when there were unmeasured characteristics in 
the model affecting both the timing of the Kasai procedure and patient outcome, and then 
the IV analysis should be used.  
I used length of stay at the last hospital prior to the Kasai procedure as a proxy for the 
accessibility to the nearest high-level hospital in IV analysis. The diagnostic test to see the 
strength of the instrument suggested that IVs were not weak in the Kasai procedure at less 
than 30 days, 45 days, 60 days, and 75 days, but not for the rest of later timing of groups. 
Wu-Hausman test confirmed that the estimates of both the models were consistent. This 
suggested that the 2SLS model was not the preferred model and suggested that the timing 





6.3. Further Research  
The results should be analyzed in the long-term outcomes. Due to limited data 
access, the study only investigated thethe short-term outcome of 1-year native liver survival 
without jaundice. However, the results on short-term outcome may not necessarily be an 
ideal proxy for long-term outcomes. Ultimately, what matters to patients is not the short-term 
prognosis, but rather how to live with the disease and how it affects their lives in the long-run. 
In the JBAR dataset, a long-term outcome measurement such as 10- 20-year native survival 
is also available but not ready for the current analysis so in the near future, such data will be 
also used to assess the longer-term effect of Kasai procedure. 
As suggested in the study findings and discussion, the effect of the timing of Kasai 
procedure differed for the different types of obstruction. Further research is warranted 
focusing on analyses using more interaction terms to see whether there is the presence of a 
significant interaction indicating the effect of the timing of Kasai procedure on the response 
variable that is different depending on the values of the other predictor variables.  
I applied only one instrument in this study and the average treatment effects for the 
particular subgroups of the study may not generalizable to the entire subjects in the study. In 
order to further verify the validity and robustness of the results, I would have to apply more 
instruments within the study in order to compare the findings from the different IV analyses. 
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This would allow examining whether the IV analyses are aligned in both directions and 
magnitudes.  
As discussed in Chapter 3 and 4, the recent government policy on the national stool color 
card implemetation launched in 2012 in Japan would be an ideal candidate to examine the 
causal effect of the timing of Kasai procesure. The current nationwide implementation of 
stool color card should provide clear insights regarding target patients and the ideal timing of 
the Kasai procedure. Although the purpose of the stool color card screening is to achieve 
the early surgical intervention, it is still not clear how early is early enough to achieve optimal 
patient outcomes. Policy makers should be clear on the goals and targets of the national 
stool color card implementation.  
Cost-effective analysis among different screening modalities is also warranted. 
Distributing a stool color card might be less expensive than taking and testing clinical 
samples such as blood or urine. However, differences in the sensitivity of screenings could 
result in variance across subsequent outcomes, leading to variation in overall efficiencies.  
It is my hope that international collaboration on pooling existing data on rare 
disease will occur in the near future which will answers to many unanswered questions  




















Figure 1 Incidence R
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Figure 4 Kaplan-Meier and the log-rank test of Survival of Native Liver at 2-, 5-, 10-, and 15 
years in France (2009) 
 
 






Figure 5 20-year transplant free survival of BA patients and timing of Kasai procedure in 
Netherland 
 


















Figure 6 Stool Color Card Chart 
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Figure 12 ROC with Full Covariates 
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Table 4 Multivariate Analysis of Survival of Native Liver Outcome in France Study (1999) 
 
Source: Chardot et al (1999) 
Table 5 Univariate and Multivariate Analysis of Survival of Native Liver in France Study 
(2013) 
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Table 7 Calculation of DiD 
 
 Exposed group Control Group Difference across groups 
T1 Yt=1 Ct=1 Yt=1 - Ct=1 
T0 Yt=0 Ct=0 Yt=0 – Ct=0 
Difference 
Across time 
D1: Yt=1 – Yt=0 D2: Ct=1 – Ct=0 DiD: (Yt=1 – Yt=0) – (Ct=1 – Ct=0) 
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Table 8 Estimated Number of BA Patients in Japan 




1989 1,247 1247000 108 
1990 1,222 1222000 108 
1991 1,223 1223000 108 
1992 1,209 1209000 108 
1993 1,188 1188000 108 
1994 1,238 1238000 108 
1995 1,187 1187000 108 
1996 1,207 1207000 108 
1997 1,192 1192000 108 
1998 1,203 1203000 108 
1999 1,178 1178000 108 
2000 1,191 1191000 108 
2001 1,171 1171000 108 
2002 1,154 1154000 108 
2003 1,124 1124000 108 
2004 1,111 1111000 108 
2005 1,063 1063000 108 
2006 1,093 1093000 108 
2007 1,090 1090000 108 
2008 1,091 1091000 108 
2009 1,070 1070000 108 
2010 1,071 1071000 108 
2011 1,051 1051000 108 
2012 1,037 1037000 108 
  
Estimated Number 
of Patients 2864 
Calculations were based on birth statistics from Ministry of Health, Labor and Welfare and the rate of 
incidence of BA reported by Nio M et al (2003).
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Table 9 Baseline Characteristics of Patients 
Variables  n(%) 
Sociodemographics 
   Sex   
 Male  956 (37) 
 Female  1643 (63) 
   Birth order, median (IQR) 2 (1-2) 
   Birth weight (g) , mean (±SD) 2916.9 (449) 
   Gestational age (wks) , mean (±SD) 38.7 (1.7) 
   Age of Parents   
 Age of Father (yrs), mean (±SD) 31.9 (5.8) 
 Age of Mother (yrs), mean (±SD) 29.5 (4.6) 
Clinical Characteristics   
   Age at Kasai (days), mean (±SD) 67.6 (29.3) 
   Types of obstructiona   
 I 101 (4) 
 I-cyst 212 (8) 
 II 54 (2)  
 III 2215 (85) 
   Associated anomalies  129 (5)  
   Cholangitis   1046 (42) 
   Use of choleretic agent   
 Dehydrocholic 1321 (50) 
 Ursodeoxycholic Acid 2270 (87) 
 Secretin 115 (4) 
 Steroid 2314 (88) 
 Glucagon 593 (22) 
 PGE1 131 (5) 
 Taurine 264 (10) 
 PG-F2α 49 (2) 
 PG-E2 229 (9) 
Hospital Characteristics  
 Caseload, mean (±SD) 50 (31) 
1-year Survival With Native Liver without 
Jaundice  




Table 10 Screening Method used Prior to Kasai Procedure 
Screening Method n(%) 
Measurement of total bile acid 8(35) 
Stool color card 4(16) 
Lipoprotein X detection  3(15) 
Others  8(34) 
Total  23(100) 
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Table 11 Bivariate Analysis on Timing of Kasai Procedure by 1-Year Native Liver Survival 
without Jaundice 
  1-year Survival  of Native Liver 
without Jaundice 
 Yes No p-value 
Timing of KP n ( %) n (%) 
 
   Less than 30 117 (7.6) 41 (3.9) <0.001 
     31 to 45 231 (14.9) 135 (13) 0.163 
     46 to 60 407 (26.2) 213 (20.4) 0.001 
     61 to 75 398 (25.6) 241 (22.6) 0.082 
     76 to90 212 (13.7) 186 (17.7) 0.004 
     91 to 105 97 (6.3) 83 (7.8) 0.135 
     106 to 120 41 (2.6) 52 (4.9) 0.002 
     over 121 48 (3.1) 103 (9.7) <0.001 





Table 12 Bivariate Analysis of Socio demographics, Clinical and Hospital Characteristics by 
1-Year Survival of Native Liver without Jaundice 
 
Variables  1-Year Survival of Native Liver without 
Jaundice  
 Yes No p-value 
Sociodemographics 
   Gender (%)    
 Male  580 (60.7)  376 (39.3)  0.38 
 Female  968 (58.9) 675 (41.1)   
   Birth order, median  2 2 0.87 
   Birth weight (g) , mean  2927 2902 0.15 
   Gestational age (wks) , mean  38.7 38.7 0.66 
   Age of Parents     
 Age of Father (yrs), mean  31.9 32.1 0.31 
 Age of Mother (yrs), mean  29.5 29.5 0.87 
Clinical Characteristics  
   Age at Kasai (days), mean  63 74 <0.000 
   Type of obstruction    <0.001 
 I (%) 74 (73.3) 27 (26.7)  
 I-cyst (%) 175 (82.6) 37 (17.5)  
 II (%) 40 (74.1)  17 (25.9)  
 III (%) 1251 (56.5) 964 (45.5)  
   Associated anomalies (%) 65 (4)  64 (6) 0.03 
   Cholangitis (%)  593 (39) 453 (47) <0.001 
   Use of choleretic agent  
 Dehydrocholic (%) 819 (53) 502 (47) 0.006 
 Ursodeoxycholic Acid (%) 1394 (90) 876 (82) <0.001 
 Secretin (%) 63 (4) 52 (5) 0.30 
 Steroid (%) 1382 (89) 932 (88) 0.36 
 PGE1 (%) 77 (5) 54 (5) 0.89 
 Taurine (%) 164 (11) 100 (9) 0.34 
 PG-F2α (%) 26 (2) 23 (2) 0.36 
 PG-E2 (%) 126 (8) 103 (10) 0.16 
Hospital Characteristics 




Table 13 Multivariate Logit and Multivariate Probit Regression on Timing of Kasai Procedure 
by 1-year Survival of native Liver without Jaundice 
 
Variables   
   Logit  Probit Ratio 
Age at Kasai Procedure (days)  
  Less than 30  
 
0.553**(2.78) 0.335**(2.83) 1.65 
  31 - 45  0.0153 (0.11) 0.00947 (0.11) 1.62 
  46 - 60   0.127 (1.09) 0.0784 (1.09) 1.62 
  61 - 75 (reference)   - -  
  76 - 90   -0.385**(-2.98) -0.240**(-2.98) 1.60 
  91- 105  -0.338*(-1.99) -0.210*(-1.98) 1.61 
  106 - 120   -0.742***(-3.31) -0.463***(-3.31) 1.60 
  Over 121   -1.299***(-6.40) -0.807***(-6.53) 1.61 
Constant  0.504***(-6.18) 0.315***(-6.24) 1.60 
N  2605 2605  





Table 14 Covariates Selection 























   Gender  × × 0.38 × 
   Birth order  × × 0.87 × 
   Birth weight  ○ × 0.15 - 
   Gestational age  × × 0.66 × 
   Age of Parents      
 Age of Father  × N/A 0.31 × 
 Age of Mother  × N/A 0.87 × 
Clinical Characteristics  
   Type of obstruction      
 I  ○ ○ 0.004 - 
 I-cyst  ○ ○ <0.001 - 
 II  ○ ○ 0.03 - 
 III  ○ ○ <0.001 - 
   Associated anomalies  ○ ○ 0.03 - 
   Cholangitis  ○ ○ <0.001 - 
   Use of choleretic agent  
 Dehydrocholic  ○ N/A 0.006 - 
 Ursodeoxycholic Acid  ○ ○ <0.001 - 
 Secretin  × × 0.30 × 
 Steroid ○ ○ 0.36 × 
 PGE1  × × 0.89 × 
 Taurine  × × 0.34 × 
 PG-F2α  × × 0.36 × 
 PG-E2  × × 0.16 × 
Hospital Characteristics 
 High Caseload ○ ○ 0.01 - 
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Table 15 Multivariate Logit Regression on Timing of Kasai Procedure by 1-year Survival of 
native Liver without Jaundice with Full Covariates vs Selected Covariates 
 Variables  
  No Covariates  Full Covariates Selected 
Covariates 
 Selected  
 Covariates + 
 Hospital FE 
 Age at Kasai Procedure (days)  
  Less than 30   0.553**(2.78) 0.2 (0.87) 0.322 (1.49)  0.458* (1.98) 
  31 - 45  0.0153 (0.11) 0.00328 (0.02) 0.00641 (0.04)  0.0706 (0.47) 
  46 - 60   0.127 (1.09) 0.072 (0.55) 0.134 (1.07)  0.137 (1.05) 
  61 - 75 
(reference)  
 - - -  
  76 - 90   -0.385**(-2.98) -0.418**  (-2.84) -0.376** (-2.73) 
 -0.370** (-2.59) 
  91- 105  -0.338*(-1.99) -0.338 (-1.74) --0.26 (-1.43)  -0.197 (-1.04) 
  106 - 120   -0.742***(-3.31) -0.836*** (-3.41) -0.767** (-3.21) 
 -0.747** (-3.05) 
  Over 121   -1.299***(-6.40) -1.312*** (-5.66) 
-1.330*** 
(-6.07) 
 -1.335*** (-5.89) 
  
   Gender   - 0.133 (1.38) -  - 
   Birth order   - 0.0118 (0.21) -  - 
   Birth weight 
(g)  
 - 0.00003 (0.26) 0.00006 (0.70)  -0.00009 (-0.96) 
   Gestational 
age (wks)  
 - -0.0222 (-0.68) -  - 
Age of Parents  
 Age of Father   - -0.00271(-0.24) -  - 
 Age of Mother   - -0.0157(-1.15) -  - 
 Clinical Characteristics 
 Type of obstruction  
 I  - 0.757** (2.87) 0.842**(3.24)  0.897*** (3.35) 
 I-cyst   - 1.487*** (6.59) 1.420***(6.83)  1.495*** (6.94) 
 II   - 0.763* (2.1) 0.897*(2.53)  0.820* (2.2) 
 III (reference)  - - - 
  Associated 
anomalies  
 - -0.411 (-1.95) -0.384 (-1.86)  -0.345 (-1.60) 




 Use of choleretic agent  - 
Dehydrocholic   - 0.187* (1.99) 0.155 (1.76)  0.0181 (0.14) 
Ursodeoxycholic 
Acid  
 - 0.587*** (3.9) 0.566*** (3.97)  0.471** (3.07) 
Secretin   - -0.163 (-0.74) -  - 
Steroid   - -0.413* (-2.40) -0.340* (-2.11)  -0.344 (-1.94) 
PGE1   - -0.0525 (-0.25) -  - 
Taurine  - 0.0371 (0.24) -  - 
PG-F2α   - -0.398 (-1.23) -  - 
PG-E2   - -0.188 (-1.17) -  - 
Hospital Characteristics 
High Caseload  0.219 (1.89) 0.255* (2.36)  - 
Constant  0.504***(-6.18) 1.79 (1.49) 0.482 (1.42)  - 
N  2605 2182 2422  2377 
Pseudo R2   0.025 0.059 0.058  - 






























rocedure (days)  
  Less than 30  
-0.6 (-3.4 - 2.2) 
-0.0981 (-1.8 - 1.6) 
-1.678 (-4.6 - 1.2) 
0.43 (-.0 - .9) 
  31 - 45 
1.256 (-.7- 3.3) 
-0.115 (-1.8 - 1.6) 
-1.819 (-4.9 - 1.3) 
0.0276 (-.3 - .3) 
  46 - 60  
1.02 (-.9- 2.9) 
-0.84 (-2.4 - .7) 
0.0919 (-3.2 - 3.4) 
0.145 (-.1- .4) 





  76 - 90  
-1.176 (-3.4 - 1.0) 
0.225 (-1.8 - 2.3) 
-3.836* (-7.5 -.1) 
-0.359* (-.6 -.1) 
  91- 105 
-1.628 ( -4.9 - 1.6) 
-0.962 (-2.9 - 1.0) 
- 
-0.213 (-.6 - .2) 
  106 - 120  
0.266 (-2.8 - 3.3) 
-0.611 (-3.2 – 2.0) 
- 
-0.832** (-1.3 -.3) 
  O
ver 121  
-0.209 (-3.5 - 3.1) 
-2.459** (-4.2 - .7) 
-4.645* (-8.5 -.8) 




   B
irth w
eight (g)  
-0.000575 (-.001 - .001) 
-0.00004 (-.0 - .0) 
-0.00005 (-.0 - .0) 







0.406 (-1.8 - 2.6) 
-1.766 (-3.5 - .0) 
- 
-0.337 (-.8 -.1) 
  C
holangitis  
-1.967* (-3.5 - -.4) 
-1.476** (-2.4 - -.5) 
-1.049 (-3.2 - 1.1) 
-0.232* (-.4 -.1) 
U








t statistics in parentheses ="* p<0.05 ** p<0.01 *** p<0.001" 
U
se of choleretic agent 
D
ehydrocholic  
0.464 (-.8 - 1.7) 
0.353 (.6 - 1.3) 
-1.169 (-3.6 - 1.2) 




4.274** (1.2 - 7.3) 
1.611* (.6 - 1.3) 
-1.521 (-4.9 - 1.9) 
0.541*** (.2 - .8) 
S
teroid  
-4.858* (-8.8 - -.9) 
-1.539 (-3.3 - .3) 
-0.0662 (-3.7 - 3.6) 







0.464 (-1.2 - 2.2) 
0.713 (-.6 - 2.0) 
1.558 (-1.3 - 4.4) 
0.253* (.0 - .5) 
C
onstant 
3.959 (-1.6 - 9.5) 
2.951 (-1.69- 4.1) 
6.439 (-1.7 - 14.6) 




















































































































































































rocedure (days)  






































































































Table 19 OLS Result of Timing of Kasai Procedure on 1-Yesr Native Liver Survival 
 















birthweight 0.000000375 0.000000335 -0.00000292 -0.00000790 -0.00000568 -0.00000605 -0.00000588
(0.02) (0.02) (-0.13) (-0.36) (-0.26) (-0.28) (-0.27)
i 0.185*** 0.183*** 0.171*** 0.173*** 0.178*** 0.183*** 0.183***
(3.63) (3.59) (3.35) (3.41) (3.50) (3.60) (3.60)
icyst 0.248*** 0.252*** 0.252*** 0.261*** 0.265*** 0.270*** 0.268***
(6.87) (7.02) (7.08) (7.40) (7.48) (7.65) (7.58)
ii 0.185** 0.188** 0.189** 0.174* 0.182** 0.185** 0.194**
(2.72) (2.76) (2.78) (2.58) (2.68) (2.74) (2.87)
cholangitis -0.0720*** -0.0720*** -0.0720*** -0.0719*** -0.0720*** -0.0701*** -0.0728***
(-3.65) (-3.65) (-3.67) (-3.68) (-3.67) (-3.59) (-3.72)
ass_anom alies -0.0686 -0.0720 -0.0758 -0.0875 -0.0744 -0.0691 -0.0691
(-1.46) (-1.53) (-1.62) (-1.87) (-1.59) (-1.48) (-1.48)
HIC 0.0558* 0.0558* 0.0593* 0.0527* 0.0517* 0.0541* 0.0544*
(2.34) (2.35) (2.50) (2.24) (2.19) (2.29) (2.30)
dehycol 0.0351 0.0364 0.0337 0.0330 0.0327 0.0354 0.0359
(1.79) (1.85) (1.72) (1.69) (1.67) (1.82) (1.84)
ursodeoxycholic
acid 0.133*** 0.132*** 0.127*** 0.129*** 0.129*** 0.130*** 0.129***
(4.13) (4.10) (3.97) (4.03) (4.02) (4.08) (4.03)
steroid -0.0759* -0.0727* -0.0697* -0.0641 -0.0735* -0.0749* -0.0804*
(-2.19) (-2.10) (-2.02) (-1.87) (-2.14) (-2.19) (-2.34)
_cons 0.532*** 0.523*** 0.505*** 0.460*** 0.425*** 0.337*** 0.293***
(7.25) (7.13) (6.90) (6.27) (5.68) (4.34) (3.59)
N 2405 2405 2405 2405 2405 2405 2405
t	 statistics	 in	 parentheses
="*	 p<0.05 	 **	 p<0.01 	 ***	 p<0.001"
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Table 20 Probit Result of Timing of Kasai Procedure on 1-Yesr Native Liver Survival 
 















1.3E-06 3.83E-07 -8E-06 -2.2E-05 -1.6E-05 -1.6E-05 -1.6E-05
birthw eight -0.02 -0.01 (-0.13) (-0.36) (-0.27) (-0.27) (-0.27)
0.541*** 0.535*** 0.508*** 0.515*** 0.525*** 0.539*** 0.537***
i -3.6 -3.56 -3.36 -3.4 -3.49 -3.58 -3.56
0.787*** 0.799*** 0.800*** 0.834*** 0.847*** 0.865*** 0.862***
icyst -6.89 -7.02 -7.05 -7.32 -7.41 -7.54 -7.49
0.535** 0.544** 0.550** 0.525* 0.535** 0.551** 0.579**
ii -2.67 -2.71 -2.73 -2.57 -2.65 -2.71 -2.84
-0.200*** -0.199*** -0.201*** -0.203*** -0.202*** -0.197*** -0.205***
cholangitis (-3.74) (-3.73) (-3.77) (-3.78) (-3.77) (-3.68) (-3.82)
-0.188 -0.197 -0.208 -0.241 -0.206 -0.189 -0.19
ass_anom alies (-1.49) (-1.56) (-1.65) (-1.91) (-1.63) (-1.50) (-1.51)
0.153* 0.154* 0.164* 0.147* 0.144* 0.151* 0.152*
H IC -2.35 -2.36 -2.51 -2.24 -2.2 -2.3 -2.32
0.0976 0.102 0.0937 0.0916 0.091 0.0992 0.101
dehycol -1.83 -1.9 -1.75 -1.71 -1.7 -1.85 -1.87
0.358*** 0.356*** 0.345*** 0.352*** 0.351*** 0.356*** 0.352***
ursodeoxycholic
acid
-4.11 -4.09 -3.96 -4.02 -4 -4.06 -4.02
-0.219* -0.212* -0.204* -0.191* -0.217* -0.222* -0.238*
steroid (-2.27) (-2.19) (-2.10) (-1.97) (-2.23) (-2.29) (-2.44)
0.0855 0.0628 0.016 -0.101 -0.192 -0.427* -0.554*
Intercept -0.43 -0.32 -0.08 (-0.50) (-0.94) (-1.99) (-2.44)
n 2405 2405 2405 2405 2405 2405 2405




Table 21 OLS +IV Result of Timing of Kasai Procedure on 1-Yesr Native Liver Survival 
 















birthweight -0.00000760 -0.00000205 -0.00000135 -0.00000950 -0.0000210 -0.0000249 -0.0000503
(-0.27) (-0.09) (-0.06) (-0.32) (-0.46) (-0.48) (-0.48)
i 0.179*** 0.180*** 0.175** 0.171** 0.161* 0.172** 0.158
(3.36) (3.42) (3.22) (2.98) (2.36) (2.94) (1.90)
icyst 0.205* 0.242*** 0.255*** 0.261*** 0.267*** 0.285*** 0.293***
(2.02) (4.90) (6.70) (7.36) (7.28) (5.53) (4.17)
ii 0.171* 0.187** 0.189** 0.172* 0.167* 0.175* 0.214*
(2.27) (2.73) (2.79) (2.34) (2.10) (2.35) (2.33)
cholangitis -0.0664** -0.0702*** -0.0725*** -0.0716*** -0.0684** -0.0622* -0.0673*
(-2.84) (-3.41) (-3.68) (-3.61) (-3.12) (-2.20) (-2.54)
ass_anom alies-0.0692 -0.0751 -0.0739 -0.0903 -0.0849 -0.0706 -0.0727
(-1.46) (-1.56) (-1.55) (-1.55) (-1.55) (-1.45) (-1.30)
HIC 0.0583* 0.0566* 0.0582* 0.0524* 0.0461 0.0524* 0.0521
(2.37) (2.37) (2.40) (2.20) (1.64) (2.11) (1.83)
dehycol 0.0325 0.0367 0.0343 0.0325 0.0268 0.0341 0.0353
(1.58) (1.87) (1.74) (1.61) (1.07) (1.66) (1.53)
ursodeoxycholicacid0.134*** 0.131*** 0.129*** 0.128*** 0.122*** 0.125*** 0.110*
(4.12) (4.08) (3.96) (3.93) (3.33) (3.58) (1.97)
steroid -0.0855* -0.0728* -0.0705* -0.0629 -0.0752* -0.0798* -0.119
(-2.10) (-2.11) (-2.04) (-1.68) (-2.13) (-2.12) (-1.22)
_cons 0.547*** 0.519*** 0.510*** 0.451** 0.249 -0.0509 -0.859
(6.72) (7.01) (6.61) (3.19) (0.54) (-0.05) (-0.33)
N 2405 2405 2405 2405 2405 2405 2405
t	 statistics	 in	 parentheses
="*	 p<0.05 	 **	 p<0.01 	 ***	 p<0.001"
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Table 22 Probit+IV Result of Timing of Kasai Procedure on 1-Yesr Native Liver Survival 
 















birthw eight -2.1E-05 -6.8E-06 -4.2E-06 -2.8E-05 -5.8E-05 -6.6E-05 -0.00011
(-0.28) (-0.11) (-0.07) (-0.34) (-0.52) (-0.57) (-0.86)
i 0.514** 0.523*** 0.518** 0.506** 0.458 0.474 0.355
-3.08 -3.36 -3.24 -2.96 -1.82 -1.8 -0.75
icyst 0.654* 0.767*** 0.807*** 0.832*** 0.822*** 0.844*** 0.71
-2.03 -5.02 -6.82 -7.2 -4.68 -4.05 -1.27
ii 0.487* 0.538** 0.550** 0.516* 0.472 0.486 0.483
-2.09 -2.66 -2.74 -2.33 -1.71 -1.65 -1.2
cholangitis -0.181* -0.194*** -0.203*** -0.202*** -0.185* -0.162 -0.144
(-2.57) (-3.43) (-3.77) (-3.66) (-2.34) (-1.41) (-0.85)
ass_anom alies -0.186 -0.206 -0.203 -0.251 -0.227 -0.18 -0.153
(-1.49) (-1.60) (-1.58) (-1.60) (-1.77) (-1.37) (-0.89)
H IC 0.158* 0.156* 0.161* 0.146* 0.123 0.136 0.111
-2.43 -2.39 -2.4 -2.18 -1.38 -1.63 -0.85
dehycol 0.0887 0.103 0.0951 0.0899 0.0713 0.0889 0.0753
-1.54 -1.92 -1.76 -1.6 -0.95 -1.39 -0.85
ursodeoxycholic
acid
0.356*** 0.354*** 0.348*** 0.349*** 0.320* 0.319* 0.229
-4.03 -4.05 -3.94 -3.86 -2.36 -2.03 -0.73
steroid -0.242* -0.212* -0.205* -0.186 -0.213* -0.220* -0.266*
(-2.33) (-2.19) (-2.11) (-1.75) (-2.14) (-2.16) (-2.48)
_cons 0.127 0.053 0.0295 -0.137 -0.673 -1.44 -2.914
-0.59 -0.26 -0.14 (-0.35) (-0.61) (-0.70) (-1.02)
N 2405 2405 2405 2405 2405 2405 2405
t	 statistics	 in	 parentheses
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